Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

 
   volgende >>
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             1491 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abdominal and pelvic stop-flow (hypoxic, chemotherapeutic loco-regional treatment): Preliminary report of a phase I study Iaffaioli, R.V.
 1997
 33 S8 p. S252-
1 p.
 artikel
2 Abnormalities in erythrocyte indexes as the new prognostic factors of laryngeal cancer treated by radiation alone Wydmański, J.
 1997
 33 S8 p. S188-
1 p.
 artikel
3 A book which is addressed to patients who are about to receive chemotheraphy Kampmann, Kirsten
 1997
 33 S8 p. S313-
1 p.
 artikel
4 Absolute bioavailability and pharmacokinetics (PK) of oral vinorelbine (VRL) in patients (pts) with solid tumors Pouzzo, C.
 1997
 33 S8 p. S247-
1 p.
 artikel
5 Acceptability of follow-up visits (FU) in long term survivors from Hodgkin's disease (HD) Mencaglia, E.
 1997
 33 S8 p. S60-
1 p.
 artikel
6 Accessing cancer care: The co-ordinating role and workload of cancer support nurses McIllmurray, M.B.
 1997
 33 S8 p. S332-
1 p.
 artikel
7 Accomodation of therapy-patient: Comfort and security Braat, C.
 1997
 33 S8 p. S313-
1 p.
 artikel
8 Accuracy of laparoscopic colorectal resection for cancer: A prospective multicenter study Köckerling, F.
 1997
 33 S8 p. S161-
1 p.
 artikel
9 Achievements in the treatment of acute myelogenous leukemia (AML) Zittoun, R.
 1997
 33 S8 p. S139-
1 p.
 artikel
10 A collaboration between hospital treatment and community health care systems for cancer patients Wille, I.-L.
 1997
 33 S8 p. S332-
1 p.
 artikel
11 A common Scottish BRCA1 mutation Renwick, A.A.
 1997
 33 S8 p. S13-
1 p.
 artikel
12 A comparative analysis between Ho's and UICC classification for nasopharyngeal carcinoma (NPC) Ciuleanu, E.
 1997
 33 S8 p. S184-S185
2 p.
 artikel
13 A comparative study between 3 venous port systems with diff. types of catheter Ponnet, G.
 1997
 33 S8 p. S328-
1 p.
 artikel
14 A comparison of clinical pharmacodynamics of different administration schedules of oral topotecan (TPT, Hycamtin®) Gerrits, C.
 1997
 33 S8 p. S244-
1 p.
 artikel
15 A comparison of different constructions of ‘support’ by specialist nurses and complementary therapists Morris, S.
 1997
 33 S8 p. S321-S322
2 p.
 artikel
16 A comparison of the psychosocial impact of breast conserving therapy and total mastectomy n breast cancer patients and their partners Yeo, W.
 1997
 33 S8 p. S60-
1 p.
 artikel
17 A core curriculum for cancer clinical trial Di Glulio, P.
 1997
 33 S8 p. S316-
1 p.
 artikel
18 Acoustic neuromas (AN) treated by fractionated stereotactic radiosurgery (FSR) Lederman, G.
 1997
 33 S8 p. S254-
1 p.
 artikel
19 Actions to improve the quality of data and data-handling in cancer clinical trials (CCT) Knoblauch, Poul
 1997
 33 S8 p. S333-
1 p.
 artikel
20 Activation of immune effector cell cytolytic activity by the alkaloid derivate Ukrain (NSC 631570) Liepins, A.
 1997
 33 S8 p. S180-
1 p.
 artikel
21 Active immunization of melanoma patients with IL-2-OR IL-4-transduced allogeneic melanoma cells Arienti, F.
 1997
 33 S8 p. S289-
1 p.
 artikel
22 Activity and tolerability of gemcitabine plus cisplatin in advanced metastatic pancreatic carcinoma Heinemann, V.
 1997
 33 S8 p. S274-S275
2 p.
 artikel
23 Activity of Gemcitablne in stage 3 or 4 ovarian cancer: Patients previously treated with cisplatin (CP)-containing regimens Friedlander, M.
 1997
 33 S8 p. S120-S121
2 p.
 artikel
24 Activity of gemcltabine in metastatic breast cancer (MBC) patients previously treated with anthracycline-containlng regimens Spielmann, M.
 1997
 33 S8 p. S149-
1 p.
 artikel
25 Acute and delayed emesls in patients with solid tumors undergoing high-dose chemotherapy with autologous stem cell support (ASCS) Ricci, S.
 1997
 33 S8 p. S57-
1 p.
 artikel
26 Acute and late toxicity in the adjuvant radiotherapy of endometrial carcinoma. Analysis of 215 patients Perez-Regadera, J.F.
 1997
 33 S8 p. S205-
1 p.
 artikel
27 Acute normal tissue radiation damage and the activities of the free radical scavenging enzymes, during the conventional and continuous radiotherapy Tamawska, Dorota
 1997
 33 S8 p. S188-
1 p.
 artikel
28 Acute renal failure in the oncological ITU: A five year retrospective study Dolan, S.
 1997
 33 S8 p. S329-
1 p.
 artikel
29 Adaptation of treatment to clinical presentation in stage 45 neuroblastoma. Results of the SFOP NBL90 study Michon, J.
 1997
 33 S8 p. S124-
1 p.
 artikel
30 Addition of oxaliplatin (Eloxatine®, LOHP) to the same leucovorin (LV) and 5 fluorouracil (5FU) bimonthly regimens after progression in patients (pts) with metastatic colorectal cancer (MCRC): Preliminary report André, T.
 1997
 33 S8 p. S165-S166
2 p.
 artikel
31 A decade of clinical investigation in elderly patients with non-Hodgkin's lymphoma: Results as reported in the literature Gornez, H.
 1997
 33 S8 p. S266-S267
2 p.
 artikel
32 Adhesion and invasion of follicular thyroid cancer is regulated by vascular endothelial growth factor (VEGF) in vitro Hoelting, Th.
 1997
 33 S8 p. S46-
1 p.
 artikel
33 Adjuvant chema-radiotherapy of rectum carcinoma: Comparison of 12 months vs. 6 months chemotherapy Queißer, W.
 1997
 33 S8 p. S243-
1 p.
 artikel
34 Adjuvant chemotherapy in Dukes' B and C colorectal cancer. A cost-effectiveness analysis Norum, J.
 1997
 33 S8 p. S244-
1 p.
 artikel
35 Adjuvant chemotherapy of Dukes C colon carcinoma: Comparison of 5-FU + levamisole (LEV) 12 months vs. 5-FU + folinic acid (FA) 12 months vs 5-FU + FA 6 months Hartung, G.
 1997
 33 S8 p. S168-
1 p.
 artikel
36 Adjuvant chemotherapy of gastric cancer with etoposide Doxorubicin and cis-platinum combination (EAP) Papacostas, P.
 1997
 33 S8 p. S282-
1 p.
 artikel
37 Adjuvant chemotherapy with ac versus high dose mitoxantrone, cyclophosphamide (MC). filgrastrlm in operable breast cancer involving 10 or more axillary lymph nodes: 3 years follow-up result Fumoleau, P.
 1997
 33 S8 p. S81-
1 p.
 artikel
38 Adjuvant cisplatin and treosulfan chemotherapy in epithelial ovarian cancer stage I–III after complete surgical resection Grischke, E.M.
 1997
 33 S8 p. S121-
1 p.
 artikel
39 Adjuvant CMF improves outcome of node negative breast cancer (BC) in premenopausal women: 10 years results of a randomized study Esple, M.
 1997
 33 S8 p. S81-
1 p.
 artikel
40 Adjuvant hormonal therapy in locally advanced prostate cancer treated by external irradiation Bolla, M.
 1997
 33 S8 p. S68-
1 p.
 artikel
41 Adjuvant radiotherapy in breast cancer and risk of ischaemic heart disease Højris, I.
 1997
 33 S8 p. S80-
1 p.
 artikel
42 Adjuvant radiotherapy in patients with stages I and II of endometrial carcinoma. Results of 215 cases Pezer-rėgadera, J.F.
 1997
 33 S8 p. S210-
1 p.
 artikel
43 Adjuvant systemic therapy (AST) for breast cancer: Facts and open questions 1997 Goldhirsch, A.
 1997
 33 S8 p. S77-
1 p.
 artikel
44 Adjuvant therapy: how effective, and for which patients? A meta- analysis Gray, Richard
 1997
 33 S8 p. S288-
1 p.
 artikel
45 Adjuvant therapy of renal cell carcinoma (RCC) with a pure cell-lysate autologous tumorvaccine (aTm) Ulbrich, C.
 1997
 33 S8 p. S89-
1 p.
 artikel
46 A dual head spect scanner with PET capability: First experience in detection of local recurrence after radiotherapy for laryngeal cancer Terhaard, C.H.J.
 1997
 33 S8 p. S188-
1 p.
 artikel
47 Advanced breast cancer: High dose toremifene in tamoxifen-refractory patients Ellmén, J.
 1997
 33 S8 p. S157-
1 p.
 artikel
48 Advanced primary and recurrent head and neck malignancies treated with interstitial thermo radiotherapy: 10-year results Seegenschmiedt, M.
 1997
 33 S8 p. S255-
1 p.
 artikel
49 Advances in conformal therapy Pötter, Richard
 1997
 33 S8 p. S137-
1 p.
 artikel
50 A feasibility study of vinorelbine (VNR) and gemcitabine (GEM) in inoperable stage IIIb-IV NSCLC Mattson, K.
 1997
 33 S8 p. S236-
1 p.
 artikel
51 A high pretreatment serum level of VEGF is associated with poor outcome in small cell lung cancer Joensuu, H.
 1997
 33 S8 p. S44-
1 p.
 artikel
52 Albumin catabolism by tumors Stehle, G.
 1997
 33 S8 p. S177-S178
2 p.
 artikel
53 Allelotype of Barrett’s adenocarcinoma: A search for novel tumour suppressor genes Dolan, K.
 1997
 33 S8 p. S12-
1 p.
 artikel
54 ALL-trans-Retinoic (ATRA) acid induces cell cycle perturbations and apoptosls in human breast cancer Mangiarotti, R.
 1997
 33 S8 p. S11-
1 p.
 artikel
55 Alteration in NK cell activity during the progression of breast cancer and it modulation by cytokine Konjević, G.
 1997
 33 S8 p. S197-
1 p.
 artikel
56 Alternating ChlVPP/PAB1OE is better than PAB1OE alone as initial chemotherapy for advanced Hodgkin's disease (HD): First results of a British National Lymphoma investigation (BNLI)/Central Lymphoma Group (CLG) study Hancock, B.W.
 1997
 33 S8 p. S262-
1 p.
 artikel
57 Alternative medicine: The viewpoint of cancer patients and their nurses Salmenperä, L.
 1997
 33 S8 p. S333-
1 p.
 artikel
58 Amelioration doxorubicin efficacy through reduction of anthracycline toxicity by calcium gluconate Bogush, T.A.
 1997
 33 S8 p. S19-S20
2 p.
 artikel
59 Amifostlne (AMI) differently influences pharmacokinetics (PK) of selected cystostatic agents (CY) Schūller, J.
 1997
 33 S8 p. S245-
1 p.
 artikel
60 Amlfostine protects against acute clsplatin/ifosfamide-induced kidney damage assessed by measurement of glomerular and tubular enzymes Bokemeyer, C.
 1997
 33 S8 p. S16-S17
2 p.
 artikel
61 Amplification of ERBB-2 (HER-2JNEU) oncogene as a potential prognostic marker for breast but not ovarian cancer in Russian group of patient Imyanitov, E.N.
 1997
 33 S8 p. S196-S197
2 p.
 artikel
62 Amplification of ERBB-2 (HER-2/NEU), ERBB-1 (HER-1) and C-MYC oncogenes often combines with the deletion of chromosome 17 short arm in human carcinomas Hanson, K.P.
 1997
 33 S8 p. S14-
1 p.
 artikel
63 A multivariate analysis of tumour biologic factor predicting response to cytotoxic treatment in advanced breast cancer Siöström, J.
 1997
 33 S8 p. S195-
1 p.
 artikel
64 Anaerobic bacteria as a potential tumour gene transfer system Lambin, P.
 1997
 33 S8 p. S220-
1 p.
 artikel
65 Anal carcinoma: Regional recurrences dependent on target volume of sphincter-sparing radio-/chemotherapy Kranzbühler, H.
 1997
 33 S8 p. S164-
1 p.
 artikel
66 Analysi of the ability of cytotoxic granule and B7-1 molecule to inhibit nodal metastases of cancer cell in patient with breast and lung cancer Kontani, K.
 1997
 33 S8 p. S197-
1 p.
 artikel
67 Analysis of a preventive-oriented strategy addressed to adults cured from a childhood cancer Masera, G.
 1997
 33 S8 p. S141-
1 p.
 artikel
68 Analysis of bcl-2 and p53 genes in patients with breast cancer Dueñas, A.
 1997
 33 S8 p. S11-
1 p.
 artikel
69 Analysis of failures and survival following local treatment of isolated local-regional recurrence (LR) of breast cancer Kamby, C.
 1997
 33 S8 p. S152-
1 p.
 artikel
70 Analysis of genomic instability by microsatellite analysis in childhood Burkitt's and large cell diffuse lymphoma Ball, L.M.
 1997
 33 S8 p. S265-
1 p.
 artikel
71 Analysis of proliferation and apoptosis in brain gliomas using MIB-1 monocional antibody and tunel labelling Heesters, M.A.A.M.
 1997
 33 S8 p. S202-
1 p.
 artikel
72 Analysis of pulmonary infections during high-dose chemotherapy (HDC) and peripheral blood stem cell autologous transplantation (PBSCT) Sola, C.
 1997
 33 S8 p. S96-
1 p.
 artikel
73 An audit of Hickman line complications in patients with solid tumours O’Neill, V.J.
 1997
 33 S8 p. S54-
1 p.
 artikel
74 An evaluation of an emesis programme for nurses Wilkinson, S.
 1997
 33 S8 p. S299-
1 p.
 artikel
75 An evaluation of etiology and risk factor of bacteremia in patient with hematological malignancy Zacharof, A.K.
 1997
 33 S8 p. S53-
1 p.
 artikel
76 A new active combination of tamoxifen (T)-vinorelbine (V)-anthraclclines in metastatic breast cancer (MBC) Nardone, L.
 1997
 33 S8 p. S160-
1 p.
 artikel
77 A new assay to detect in situ colony formation in pig epidermis as a possible estimate for radiosensitivity van den Aardweg, G.J.M.J.
 1997
 33 S8 p. S23-
1 p.
 artikel
78 A new doctor-patient information link: The “triple brochure” project as a model Gaisser, A.
 1997
 33 S8 p. S61-
1 p.
 artikel
79 Angiogenesis and biology — Correlation in liver tumor Ueda, K.
 1997
 33 S8 p. S50-
1 p.
 artikel
80 Angio-genesis-inhibition and intra-arterial chemotherapy — A new modality treatment for advanced and metastatic pancreatic carcinoma Müller, H.
 1997
 33 S8 p. S50-
1 p.
 artikel
81 Angiosarcoma of the breast after lumpectomy and radiotherapy for early breast cancer: The key to an early diagnosis Molderez, C.M.
 1997
 33 S8 p. S84-
1 p.
 artikel
82 An III study comparing orchidectomy (Ctr) and orchidectomy plus mitomycin C (Exp: 15 mg/m2 intravenously q6 wks until progression) with respect to quality of life In patients with poor prognosis M1 prostate cancer Fossa, S.
 1997
 33 S8 p. S29-
1 p.
 artikel
83 An introduction to gene therapy Blankenstein, T.
 1997
 33 S8 p. S6-
1 p.
 artikel
84 An in vivo model for multiple myeloma Gramatzki, M.
 1997
 33 S8 p. S90-
1 p.
 artikel
85 An obvious and underestimated predictive assay: Precise, cheap and easy prediction of radiotherapy outcome using tumor volume Dubben, Hans-Hermann
 1997
 33 S8 p. S97-S98
2 p.
 artikel
86 An overview of 3 phase II trials of navelbine (NVB), and fractionated doses of cisplstin (CDDP) in the management of advanced non-small cell lung cancer (NSCLC) Pawlicki, M.
 1997
 33 S8 p. S236-
1 p.
 artikel
87 Anthracycline as second line chemotherapy (CT) for metastatic breast cancer (MBC) patients previously treated with taxotere (TXT) Delecroix, V.
 1997
 33 S8 p. S150-
1 p.
 artikel
88 Antiblastic activity bifunctional platinum-6-mercaptopurin and monoclonal antibody conjugate Plotnikov, V.
 1997
 33 S8 p. S96-
1 p.
 artikel
89 Antibody-guided cytokine therapy (AGCT) chemoresistant human breast cancer Giannios, John
 1997
 33 S8 p. S8-
1 p.
 artikel
90 Antibody-mediated cytotoxic therapy eradicates chemoreslstant breast cancer Giannios, John
 1997
 33 S8 p. S83-
1 p.
 artikel
91 Antibody-targeted activation of cellular immunity Weiner, L.
 1997
 33 S8 p. S69-S70
2 p.
 artikel
92 Antibody therapy of lympold malignancies: Experience with CD52 (CAMPATH-1) antibodies Dyer, M.J.S.
 1997
 33 S8 p. S69-
1 p.
 artikel
93 Anti-idiotypes for immunotherapy of breast cancer — Tumor control in an in-vivo model Köhler, S.
 1997
 33 S8 p. S8-
1 p.
 artikel
94 Antimetastatic activity of viral oncolysates Urazova, L.
 1997
 33 S8 p. S90-
1 p.
 artikel
95 Antisense oligonucleotides in cancerology Bertrand, J.R.
 1997
 33 S8 p. S219-
1 p.
 artikel
96 Antitumor activity of MTX-SA conjugates in rats Wunder, A.
 1997
 33 S8 p. S178-S179
2 p.
 artikel
97 Antitumoral effects of octadecylphosphocholine analogous Massing, U.
 1997
 33 S8 p. S175-
1 p.
 artikel
98 Antitumor effect oxygenic complexes of cobalt Šimkevičienė, V.
 1997
 33 S8 p. S181-
1 p.
 artikel
99 Antitumour activity of acid labile transferrin and albumin doxorubicin conjugates in in vitro and in vivo human tumour xenograft models Kratz, F.
 1997
 33 S8 p. S175-
1 p.
 artikel
100 Aortic-stop-f1ow-infusion (ASF) in patients with unresectable pancreatic cancer Lorenz, M.
 1997
 33 S8 p. S280-
1 p.
 artikel
101 A pathogenetic role for prostate-specific antigen (PSA) in osteoblastic bone metastasis: Implications for drug treatment of hormone-resistant disease Doherty, A.
 1997
 33 S8 p. S29-
1 p.
 artikel
102 A phase I clinical trial of the matrix metalloproteinase inhibitor, marimastat, administered concurrently with carboplatin, to patients with relapsed ovarian cancer Thomas, H.
 1997
 33 S8 p. S246-
1 p.
 artikel
103 A phase III randomised study of carboplatin and amifostine (A) vs carboplatin and G-CSF in patients with inoperable non small cell lung cancer (NSCLC) Anderson, H.
 1997
 33 S8 p. S16-
1 p.
 artikel
104 A phase III trial comparing vorozole (RIVIZOR™) versus aminoglutethimlde in the treatment of advanced postmenopausal breast cancer Bengtsson, N.-O.
 1997
 33 S8 p. S148-
1 p.
 artikel
105 A phase II study of chronomodulated (CHR) 5-fluorouracil (5-FU) and leucovorin (LV) in combination with epirubicin (EPIDX)and Cis-Platin (CDDP) in the treatment of metastatic gastric carcinoma (MGC) Bertuccelli, M.
 1997
 33 S8 p. S278-
1 p.
 artikel
106 A phase II study of interferon alpha-2a (IFNα) and modulated 5-f1uorouracil (5-FU)in patients (pts) with advanced neuroendocrine tumours (NET) Papamlchael, D.
 1997
 33 S8 p. S273-
1 p.
 artikel
107 A phase II study of primary intraperitoneal paclitaxel combined with CBDCA/cytoxan (CC) in primary OC Willemse, P.H.B.
 1997
 33 S8 p. S120-
1 p.
 artikel
108 A phase II study of topotecan given as a continuous 21-day infusion every 28 days in platinum pre-treated ovarian carcinoma Johnson, S.
 1997
 33 S8 p. S120-
1 p.
 artikel
109 A phase II-study on intense weekly 24-hour intraarterial infusion with 5-fluorouracil (5-FU) and folinic acid (FA) for colorectal liver metastases Lorenz, M.
 1997
 33 S8 p. S169-
1 p.
 artikel
110 A phase II study with Gl147211 in ovarian cancer Wanders, J.
 1997
 33 S8 p. S118-
1 p.
 artikel
111 A phase II trial of methotrexate, vinblastine, doxorubicin, and clsplatin (MVAC) in metastatic cancer of the uterine cervix Papadimitriou, C.A.
 1997
 33 S8 p. S212-
1 p.
 artikel
112 A phase II trial of radiochemotherapy with ifosfamide/mesna in patients with unresectable non small cell lung cancer (NSCLC) Bischoff, H.G.
 1997
 33 S8 p. S239-
1 p.
 artikel
113 A phase II trial of trimetrexate (TMTX), 5-fluorouracil (5-FU) and folinic acid (FA) in untreated patients with advanced colorectal carcinoma Kreuser, E.D.
 1997
 33 S8 p. S169-
1 p.
 artikel
114 A phase I study of MTA (multi-targeted antifolate, LY231514) plus cisplatin (CIS) in patients with advanced solid tumours Thoedtmann, R.
 1997
 33 S8 p. S247-
1 p.
 artikel
115 A phase I study to investigate alternate sequencing of the combination gemcitabine followed by carboplatin in NSCLC Carmichael, J.
 1997
 33 S8 p. S230-
1 p.
 artikel
116 A phase I study with S-1, an oral 5-FU formulation, in patients with solid tumors Van Groeningen, C.J.
 1997
 33 S8 p. S244-
1 p.
 artikel
117 A phase I trial of escalating repeated doses of PNU-214565 in patients with advanced colorectal and other gastrointestinal adenocarcinomas Nielsen, S.E.
 1997
 33 S8 p. S88-
1 p.
 artikel
118 A phase I trial of gemcitabine plus paclitaxel combination therapy in patients with refractory solid tumors Sandler, A.
 1997
 33 S8 p. S248-
1 p.
 artikel
119 A pilot study of VIME-C/P or VIME, in patients with small cell lung cancer Söderberg, M
 1997
 33 S8 p. S239-S240
2 p.
 artikel
120 A pilot study to compare two physiotherapy treatment regimes for patients receiving radiotherapy for carcinoma of the respiratory tract or lungs Taylor, B.
 1997
 33 S8 p. S323-
1 p.
 artikel
121 A placebo-controlled study of epoetin alfa in multiple myeloma (MM) patients with anaemia Dammacco, F.
 1997
 33 S8 p. S90-
1 p.
 artikel
122 Apoptosis induction by fludara and anti-Fas monoclonal antibodies on B-chronic lymphocytic leukemia cells Volkova, M.A.
 1997
 33 S8 p. S92-S93
2 p.
 artikel
123 Apoptosls corrected proliferation fraction in childhood sarcoma shows binominal distribution suggestive of switch mechanism in proliferation control Ball, L.M.
 1997
 33 S8 p. S14-S15
2 p.
 artikel
124 Apoptosls in cancer Debatin, K.-M.
 1997
 33 S8 p. S225-
1 p.
 artikel
125 Application of a novel growth suppressing gene, tob, for gene therapy of pancreatic cancer in vitro Yanagie, H.
 1997
 33 S8 p. S88-
1 p.
 artikel
126 A prospective randomlsed trial of protracted venous infusion (PVI) 5-FU with or without mitomycin C (MMC) in advanced colorectal cancer Ross, P.
 1997
 33 S8 p. S242-
1 p.
 artikel
127 A prospective study on Intratumoral microvessel density (IMD), p53-protein expression and prognosis in colorectal cancer Vermeulen, P.
 1997
 33 S8 p. S45-
1 p.
 artikel
128 A Radiation-technologist as quality controle officer: An evolution in quality? Bate, M-Th.
 1997
 33 S8 p. S334-
1 p.
 artikel
129 A randomised, double blind, parallel- group trial to evaluate the effect of the aromatase inhibitor anastrozole on the pharmacokinetics of tamoxifen (TAM) in postmenopausal breast cancer patients Tobias, J.S.
 1997
 33 S8 p. S249-
1 p.
 artikel
130 A randomized clinical trial comparing SC interleukin-2, SC Alpha-2A-interferon, and IV bolus 5-fluorouracil against oral tamoxifen in progressive metastatic renal cell carcinoma patients Atzpodien, J.
 1997
 33 S8 p. S36-S37
2 p.
 artikel
131 A randomized single-institution study of high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin (CTC) in apical node-positive breast cancer Rodenhuis, S.
 1997
 33 S8 p. S217-
1 p.
 artikel
132 A randomized trial of IFNα/IL-2 with or without CDDP in advanced melanoma: An EORTC melanoma cooperative group trial Keilholz, U.
 1997
 33 S8 p. S256-
1 p.
 artikel
133 Are disseminated tumor cells detected by RT-PCR In patients with colorectal cancer of prognostic value? Vogel, I.
 1997
 33 S8 p. S160-S161
2 p.
 artikel
134 Are new anthracycline dose recommendations needed for patients with liver dysfunction? Dobbs, N.A.
 1997
 33 S8 p. S155-S156
2 p.
 artikel
135 Are patients with lymphoedema being given enough information to manage their own programme of care? Green, Gene
 1997
 33 S8 p. S322-
1 p.
 artikel
136 Are serum TPS levels important in the prognosis of lung cancer? Uner, A.
 1997
 33 S8 p. S49-
1 p.
 artikel
137 A review of the fractionation trials in head and neck cancer Bentzen, Søren M.
 1997
 33 S8 p. S290-
1 p.
 artikel
138 Aromatherapy as an anxiety management programme for patients with cancer Wilkinson, S.
 1997
 33 S8 p. S63-
1 p.
 artikel
139 Arranging the transportation of biologic samples: Beware of the implications! de Boer, M.
 1997
 33 S8 p. S330-
1 p.
 artikel
140 A rule based system for prediction of radiation induced tissue injury Busch, M.
 1997
 33 S8 p. S106-
1 p.
 artikel
141 A seven-years experience with implantable devices for regional hepatic arterial chemotherapy: Usability time, incidence and management of complications Formentini, A.
 1997
 33 S8 p. S164-S165
2 p.
 artikel
142 Assessing patient satisfaction with radiation therapy information Samant, A.
 1997
 33 S8 p. S312-
1 p.
 artikel
143 Assessment of quality of life in incurable cancer patients in the First Moscow Hospice Parkhomenko, Elena V.
 1997
 33 S8 p. S56-
1 p.
 artikel
144 Association of tumour growth on nude mice and poor outcome in soft tissue sarcoma (STS) patients Budach, W.
 1997
 33 S8 p. S109-
1 p.
 artikel
145 A summary on dose escalation using CHARTWEL in non-small cell carcinoma of the bronchus Saunders, M.I.
 1997
 33 S8 p. S231-
1 p.
 artikel
146 Augmentation of antitumor activity of 5'-deoxy-5-f1uorourldlne by IL-12 through the up-regulation of pyrimidine nucleoside phosphorylase in murine tumor models Tanaka, Y.
 1997
 33 S8 p. S176-S177
2 p.
 artikel
147 Australian public cancer information messages in 1996. How well do the messengers agree? Kober, T.
 1997
 33 S8 p. S311-
1 p.
 artikel
148 Author index 1997
 33 S8 p. S341-S374
34 p.
 artikel
149 Autoimmunity induced by interleukin-2 and interferon-α is associated with long-term survival in patients with metastatic renal cell carcinoma Franzke, A.
 1997
 33 S8 p. S39-
1 p.
 artikel
150 Axillary dissection — How and when do I do it? Salvadori, B.
 1997
 33 S8 p. S77-
1 p.
 artikel
151 Bax expression, apoptosis and proliferation prior and after preoperative radiochemo-therapy for locally advanced rectal cancer Tannapfel, Andrea
 1997
 33 S8 p. S22-S23
2 p.
 artikel
152 Bcl2 and p53 expression in platinum and irradiation sensitive and resistant human ovarian cancer cells De Pooter, Ch.
 1997
 33 S8 p. S88-
1 p.
 artikel
153 Bcl-2 expression is reduced and reciprocal to p53 and c-myc expression in advanced human colorectal cancer Popescu, R.A.
 1997
 33 S8 p. S165-
1 p.
 artikel
154 Bcl-2/p53 expression and TP53 mutations: Correlations with in vitro radiosensitivity in patients with head and neck squamous cell carcinoma Stausbøl-Grøn, B.
 1997
 33 S8 p. S23-
1 p.
 artikel
155 Bendamustin — Relapse therapy in patients with low grade non Hodgkin's lymphoma (NHL) Heider, A.
 1997
 33 S8 p. S270-
1 p.
 artikel
156 Bereavement in the final phase of live — Different perspectives: The various faces of existential grief Temestedt, Britt-Marie
 1997
 33 S8 p. S318-
1 p.
 artikel
157 Bilateral germ cell tumors of the testis (GCTT): Report of two institutions experience Argirovic, Dj.
 1997
 33 S8 p. S41-
1 p.
 artikel
158 Bilateral testicular germ cell tumors (TGCT) Gerl, A.
 1997
 33 S8 p. S40-S41
2 p.
 artikel
159 Bilirubin: Baseline value and transient increase of total bilirubin (Bll) may be used as good predictor of CPT-11'S toxicity Wasserman, E.
 1997
 33 S8 p. S245-
1 p.
 artikel
160 Binding of toremifene to human serum proteins: Study on potential interactions between toremlfene and other highly protein-bound drugs in vitro Laakso, S.
 1997
 33 S8 p. S251-
1 p.
 artikel
161 Biodistribution and antitumor activity of drugs encapsulated in thermosensitive Iiposomes in tumor bearing mice Cividalli, A.
 1997
 33 S8 p. S176-
1 p.
 artikel
162 Biological activity of thiocoraline, a novel marine depsipeptide Faircloth, G.
 1997
 33 S8 p. S175-
1 p.
 artikel
163 Biological factors predicting the outcome of regional chemotherapy in colorectal carcinoma metastases to liver Zaloudik, J.
 1997
 33 S8 p. S167-
1 p.
 artikel
164 Biological predictors of endocrine response in advanced breast cancer Nicholson, R.I.
 1997
 33 S8 p. S216-
1 p.
 artikel
165 Biology and treatment of primary gastric lymphoma Koch, Peter
 1997
 33 S8 p. S221-
1 p.
 artikel
166 Bispeciffic antibody MDX210 (FcγRI × HER-2/neu) in combination with G-CSF: Results of a phase I trial in patients with metastatic breast cancer Valerius, Th.
 1997
 33 S8 p. S152-
1 p.
 artikel
167 Biweekly administration of methotrexate (MTX), levofolinic acid (LFA), and 5-fluorouracil (5-FU) in advanced colorectal carcinomas Casaretti, R.
 1997
 33 S8 p. S167-
1 p.
 artikel
168 Blood and bone marrow transplantation in the ambulatory setting Porter, H.
 1997
 33 S8 p. S333-
1 p.
 artikel
169 Bolus injection versus short-term infusion of 5-fluorouracil in patients with advanced colorectal cancer: A prospective randomized trial Berglund, Å.
 1997
 33 S8 p. S242-
1 p.
 artikel
170 BOMP/EPI intensive chemotherapy in poor-prognosis Germ Cell Tumors (GCT) Tabemero, J.M.
 1997
 33 S8 p. S39-
1 p.
 artikel
171 Brachytherapy improves outcome of radiotherapy for soft-tissue sarcoma of the extremities Ben-Josef, E.
 1997
 33 S8 p. S111-
1 p.
 artikel
172 Brachytherapy in oesophageal cancer the radical role Rowland, Chris G.
 1997
 33 S8 p. S292-
1 p.
 artikel
173 Brain metastases (BM) in breast cancer (BC): Prognostic factors and management in 162 patients Lentzsch, S.
 1997
 33 S8 p. S156-
1 p.
 artikel
174 Brain metastases from colon- and rectumcarcinoma Nieder, C.
 1997
 33 S8 p. S168-
1 p.
 artikel
175 BRCA1 mRNA expression and allel loss at chromosome 17q21 in sporadic breast and ovarian carcinoma Beckmann, M.W.
 1997
 33 S8 p. S9-
1 p.
 artikel
176 Breast cancer predisposition genes Black, D.M
 1997
 33 S8 p. S67-
1 p.
 artikel
177 Breast cancer: The nurse's role in genetic counselling Ferrario, R.
 1997
 33 S8 p. S332-S333
2 p.
 artikel
178 Breast cancer: Tumor excision + continuous Tamoxifen (TET) compared with modified radical mastectomy (MRM) in patients over 70 years of age with operable breast cancer van Zyl, J.A.
 1997
 33 S8 p. S82-
1 p.
 artikel
179 Breast conserving surgery and PDR-Brachytherapy for recurrent breast cancer after primary breast conserving treatment Including EBT and HDR-Brachytherapy — Preliminary results Resch, A.
 1997
 33 S8 p. S159-S160
2 p.
 artikel
180 Breast & ovarian cancer risk in BRCA mutation carriers: Implications for prevention Catane, R.
 1997
 33 S8 p. S12-S13
2 p.
 artikel
181 Breathlessness — Perspectives on management Corner, J.
 1997
 33 S8 p. S318-
1 p.
 artikel
182 Bridging the gap, integrating theory and practice for nurses new to oncology Collins, P.
 1997
 33 S8 p. S334-
1 p.
 artikel
183 CAF vs CMF both with tamoxlfen in postmenopausal patients with advanced breast cancer — A randomized study with more than 10 years follow-up from the Danish breast cancer cooperative group Andersson, M.
 1997
 33 S8 p. S146-
1 p.
 artikel
184 CA125 mimicry by SCFV-fragments of the monoclonal anti-idiotypic antibody ACA125 for immunotherapy of ovarian cancer Reinartz, S.
 1997
 33 S8 p. S123-
1 p.
 artikel
185 Camptothecins Hanauske, Axel-R.
 1997
 33 S8 p. S218-
1 p.
 artikel
186 Cancer apoptosis: A possible novel tool to evaluate prognosis and effectiveness of therapy in breast and colon cancer Carreca, I.
 1997
 33 S8 p. S48-
1 p.
 artikel
187 Cancer genetics knowledge of doctors treating cancer patients Stefanova, M.
 1997
 33 S8 p. S14-
1 p.
 artikel
188 Cancer incidence in postmenopausal uterine bleedings: Diagnostic value of ultrasound, hysteroscopy and fractional D&C Krause, A.
 1997
 33 S8 p. S209-
1 p.
 artikel
189 Cancer In the elderly — An increasing problem with no clear solution Moat, S.
 1997
 33 S8 p. S339-
1 p.
 artikel
190 Cancer in the elderly — Are there different needs for information? An evaluation of calls to the German cancer information service Wilcke, S.
 1997
 33 S8 p. S61-S62
2 p.
 artikel
191 Cancer in twins Verkasalo, Pia
 1997
 33 S8 p. S128-
1 p.
 artikel
192 Cancer nursing education in Europe Jodrell, N.
 1997
 33 S8 p. S73-
1 p.
 artikel
193 Cancer nursing in Europe: A nursing perspective Bond, P.
 1997
 33 S8 p. S331-
1 p.
 artikel
194 Cancer patient education & information: Development of a new structured information package DeZeeuw, N.
 1997
 33 S8 p. S312-
1 p.
 artikel
195 Cancer patient information and support Keskinen, Leena
 1997
 33 S8 p. S62-
1 p.
 artikel
196 Cancer phenotype in 19 families with TP53 mutations Birch, J.M.
 1997
 33 S8 p. S12-
1 p.
 artikel
197 Cancer predisposing genes Ponder, B.A.J.
 1997
 33 S8 p. S66-
1 p.
 artikel
198 Cancer publication trends, 1966–1995 Stalpers, Lukas J.A.
 1997
 33 S8 p. S129-
1 p.
 artikel
199 Cancer registries for quality assurance: Experience in Southeastern Netherlands Coebergh, J.W.W.
 1997
 33 S8 p. S128-
1 p.
 artikel
200 Cancer rehabilitation: The development of a programme Koppeian-Rensenbrink, A.G.
 1997
 33 S8 p. S321-
1 p.
 artikel
201 Cancer research priorities: The discrepancy between research needs and research output Stalpers, Lukas J.A.
 1997
 33 S8 p. S128-
1 p.
 artikel
202 Cancer reviews need to be systematic if they are to be reliable Williams, Chris
 1997
 33 S8 p. S128-S129
2 p.
 artikel
203 ‘Cancer — testis’ antigen-expression in prostate carcinoma Jāger, Dirk
 1997
 33 S8 p. S35-
1 p.
 artikel
204 Cancer treatment and fertility preservation Delbeke, L.O.
 1997
 33 S8 p. S72-
1 p.
 artikel
205 Can sentinel lymph node biopsy avoid axillary dissection in NO breast cancer patients? Zurrida, S.
 1997
 33 S8 p. S79-
1 p.
 artikel
206 Can surgery be replaced by radio-chemotherapy in the treatment of esophageal cancer? von Briel, Ch.
 1997
 33 S8 p. S276-
1 p.
 artikel
207 Carboplatin as part of each fraction of treatment: Potential for improvement upon hyperfractionated irradiation in advanced head and neck cancer Villar, A.
 1997
 33 S8 p. S187-
1 p.
 artikel
208 Carboplatin (CBDCA), ifosfamide (IFX) and etoposide (VP) in advanced non small cell lung cancer (NSCLC): A phase II trial Candamio, S.
 1997
 33 S8 p. S240-
1 p.
 artikel
209 Carboplatin (CBDCA) + radiotherapy (RT) vs RT in inoperable stage III–IV head and neck (HN) carcinoma Airoldi, M.
 1997
 33 S8 p. S187-
1 p.
 artikel
210 Carboplatin plus vinorelbine: A new active regimen in extensive small cell lung cancer. Results of a multicenter phase II study Gridelli, C.
 1997
 33 S8 p. S231-
1 p.
 artikel
211 Cardiac function late after anthracycline (AX) therapy for pediatric cancer. A multicentric study of the german society of pediatric oncology and hematology (GPOH) Bielack, S.
 1997
 33 S8 p. S18-
1 p.
 artikel
212 Cardiac late effects after anthracyclines Bielack, S.
 1997
 33 S8 p. S141-
1 p.
 artikel
213 Cardiac lesions after mediastinal Irradiation (r) for Hodgkin's disease (HD) Gianzmann, C.
 1997
 33 S8 p. S264-
1 p.
 artikel
214 Cardioprotective efficacy of amifostine (WR-2721) in adriamycine-treated rats Dobrić, S.
 1997
 33 S8 p. S21-
1 p.
 artikel
215 Caregiver burden among partners of cancer patients Nijboer, C.
 1997
 33 S8 p. S74-
1 p.
 artikel
216 Care principles of chronic oedema management Bird, A.
 1997
 33 S8 p. S322-S323
2 p.
 artikel
217 148 cases of vulvar cancer — Results of radical surgical treatment Ebert, E.
 1997
 33 S8 p. S208-
1 p.
 artikel
218 CD22 as target for radioimmunotherapy of hematological malignancies of B-cell origin (non-Hodgkin's lymphoma, acute lymphatic leukemia and macroglobulinemia) Behr, T.M.
 1997
 33 S8 p. S262-
1 p.
 artikel
219 CD44-isoforms promote adhesion to endothelial cells through recognition of chondroitln-4-sulfate Droll, A.
 1997
 33 S8 p. S47-
1 p.
 artikel
220 CEA-Scan® immunoscintigraphy in the imaging and diagnosis of breast cancer Goldenberg, D.M.
 1997
 33 S8 p. S82-
1 p.
 artikel
221 CEF chemotherapy for advanced gastro-oesophageal cancer Lacko, A.
 1997
 33 S8 p. S281-
1 p.
 artikel
222 Cell-cycle dependant expression of the proliferation associated Ki-67 antigen Duchrow, M.
 1997
 33 S8 p. S45-
1 p.
 artikel
223 Cell cycling related nuclear antigen expression and detection of hyperplasia in routine endometrial biopsy Liston, R.
 1997
 33 S8 p. S208-
1 p.
 artikel
224 Cellular and molecular mechanisms of cancer invasion Mareel, M.
 1997
 33 S8 p. S78-
1 p.
 artikel
225 Cellular mechanism of the novel imidazoacridinone antineoplastic agent C1311 Burger, A.M.
 1997
 33 S8 p. S174-
1 p.
 artikel
226 Cellular mechanisms of resistance to methotrexate in childhood leukemia Weigand, M.
 1997
 33 S8 p. S174-
1 p.
 artikel
227 Central venous access removal in a haemato-oncology unit: A prospective audit Stephens, Moira
 1997
 33 S8 p. S301-
1 p.
 artikel
228 Cervical cancer screening: Results of two tears of a French pilot study in 3 districts of Lyon suburbs Mignotte, H.
 1997
 33 S8 p. S211-S212
2 p.
 artikel
229 Cervical tumors: Stages of the disease, level of differentiation, presence of HPV and loss of heterozygocity Sakharova, O.
 1997
 33 S8 p. S210-
1 p.
 artikel
230 Change in expression of the adhesion molecule CD66a in different stage of human breast carcinogenesis Lisboa, B.W.
 1997
 33 S8 p. S196-
1 p.
 artikel
231 Change in radiation exposed women's mammary gland Gurieva, V.
 1997
 33 S8 p. S197-
1 p.
 artikel
232 Changes in the incidence and survival rate of cervical cancer in patients under age of 30 years Garadnay, B.
 1997
 33 S8 p. S130-
1 p.
 artikel
233 Changes in tumor oxygenation in split course radiochemotherapy (RCTh) Stadler, P.
 1997
 33 S8 p. S185-S186
2 p.
 artikel
234 Changes of self-concept and body image due to cancer recurrence Münstedt, K.
 1997
 33 S8 p. S61-
1 p.
 artikel
235 Changing working practices from full time to job share an overview of two oncology Research Nurses's experience Woodhull, J.
 1997
 33 S8 p. S334-
1 p.
 artikel
236 Characterization of multidrug resistant Ehrlich ascites tumor cells (EHR2) selected for resistance to mitoxantrone (MITOX) Nieisen, D.
 1997
 33 S8 p. S178-
1 p.
 artikel
237 Chemoimmunotherapy with weekly cisplatin and etoposide plus S.C. rIL-2 plus oral medroxyprogesterone acetate (MPA) in stage IIIB-IV NSCLC: Preliminary results on clinical response and on immunologic assessment Mantovani, G.
 1997
 33 S8 p. S239-
1 p.
 artikel
238 Chemoprevention with interferon alfa and 13-CIS retinoic acid in patients with advanced head and neck cancer Büntzel, J.
 1997
 33 S8 p. S193-
1 p.
 artikel
239 Chemotherapy administration — Can we achieve evidence based practice? Goodman, I.D.
 1997
 33 S8 p. S299-
1 p.
 artikel
240 Chemotherapy for heavily pretreated patients (pts.) with bone (BS) and soft tissue (STS) sarcomas Reichardt, P.
 1997
 33 S8 p. S111-
1 p.
 artikel
241 Chemotherapy in advanced ovarian cancer (AOC) Lonescu goga, S.
 1997
 33 S8 p. S122-
1 p.
 artikel
242 Chemotherapy in locally advanced head and neck squamous cell carcinoma (HNSCC): Preliminary results of a meta-analysis using individual patient data of randomized trials Pignon, J.P.
 1997
 33 S8 p. S290-
1 p.
 artikel
243 Chemotherapy of relapsing glioblastoma multiforme IV (GBM IV)with fotemustine (F) and dacarbacine (D) Fazeny, B.
 1997
 33 S8 p. S204-
1 p.
 artikel
244 Chemotherapy with vlnorelblne (navelbine: NVB) + carboplatin in advanced non-small cell lung cancer (NSCLC) Parente, B.
 1997
 33 S8 p. S241-
1 p.
 artikel
245 Childhood cancer mortality in Austria, 1980–1992 Kunze, U.
 1997
 33 S8 p. S127-
1 p.
 artikel
246 Children's reactions to parents with cancer Nelson, E.
 1997
 33 S8 p. S74-
1 p.
 artikel
247 Chromatin structure in human glioma cell lines with different radiosensitivity Schlenger, L.
 1997
 33 S8 p. S25-
1 p.
 artikel
248 Chromophilic renal cell carcinoma: Characterization of four permanent cell lines Ramp, U.
 1997
 33 S8 p. S42-
1 p.
 artikel
249 Chromosomal alterations associated with malignancy in head and neck cancer Bockmühl, Ulrike
 1997
 33 S8 p. S184-
1 p.
 artikel
250 8 -CI-cAMP induction of differentiation and apoptosis in Y-79 human retinoblastoma cell line Fasslna, G.
 1997
 33 S8 p. S181-S182
2 p.
 artikel
251 Cisplatin, etoposide and bleomycin infusion (PEBI regimen) in good-risk patients with germ cell tumors Colleoni, M.
 1997
 33 S8 p. S42-
1 p.
 artikel
252 Cisplatin/paclitaxel vs carboplatin/paclitaxel: Optimizing of treatment in advanced ovarian cancer Möbus, V.
 1997
 33 S8 p. S119-
1 p.
 artikel
253 Cladribine (CdA) therapy in chronic lymphocytic leukemia (CLL) - Long-term follow-up of 117 patients Juliusson, Gunnar
 1997
 33 S8 p. S90-S91
2 p.
 artikel
254 Clearance of lymphadenopathy in epidermoid carcinomas treated by radiotherapy (RT) Ohara, K.
 1997
 33 S8 p. S100-
1 p.
 artikel
255 Clinical activity of the monoclonal antibody (MAB) IDEC-C2B8 in patients (pts) with relapsed low-grade or follicular NHL (R-LG/F NHL) Grillo-López, A.J.
 1997
 33 S8 p. S260-S261
2 p.
 artikel
256 Clinical and microbiological evaluation of radiotherapy (RT) induced mucositis in head and neck cancer patients Holmskov, K.
 1997
 33 S8 p. S184-
1 p.
 artikel
257 Clinical and pharmacokinetic phase I study with Cematodin® given as continuous 24-hour intravenous infusion Mross, K.
 1997
 33 S8 p. S248-
1 p.
 artikel
258 Clinical and pharmacokinetic phase I study with taxol® given as short 1-hour intravenous infusion Mross, K.
 1997
 33 S8 p. S251-
1 p.
 artikel
259 Clinical and pharmacoklnetic evaluation of the new blsnaphtalamlde LU 79553 administered every 21 days in patients with solid tumors: An EORTC/ECSG study Thōdtmann, R.
 1997
 33 S8 p. S244-S245
2 p.
 artikel
260 Clinical course, prognosis and therapy of bone metastases in breast cancer patients Diel, I.J.
 1997
 33 S8 p. S150-
1 p.
 artikel
261 Clinical evaluation of azasetron tablets in prevention of cisplatin-induced acute emesis — Multicenter double blind test with ondansetron tablets as control Mori, K.
 1997
 33 S8 p. S20-
1 p.
 artikel
262 Clinical experience with cross section imaging based conformal treatment planning procedures at 486 interstitial brachytherapy applications Kovács, G.
 1997
 33 S8 p. S102-
1 p.
 artikel
263 Clinical factors predictive of the probability of upstaging patients with clinical stage (CS) I or II supradiaphragmatic Hodgkin's disease (HD) to pathological stage (PS) III2 or IV by staging laparotomy Aragón, G.
 1997
 33 S8 p. S264-
1 p.
 artikel
264 Clinical impact of fusion transcripts detected in soft tissue liposarcoma and synovial sarcoma Willeke, F.
 1997
 33 S8 p. S109-
1 p.
 artikel
265 Clinical impact of immunosclntigraphy with 99mTc-labeled anti-cea Fab′ in the follow-up of colorectal cancer patients: Prediction of surgical resectability from the combination with CT Becker, W.
 1997
 33 S8 p. S161-
1 p.
 artikel
266 Clinical importance of digital thorax X-rays for detection of lung infiltrations of bone marrow transplanted patients — A prospective study Weber, Ch.
 1997
 33 S8 p. S55-
1 p.
 artikel
267 Clinical prognostic factors (PF) for survival in non small cell lung cancer (SCLC). Can they add something new? Results of a prospective multicenter study Fuentes, R.
 1997
 33 S8 p. S234-
1 p.
 artikel
268 Clinical radiobiology of glottic T1 squamous cell carcinoma Tamawski, Rafal
 1997
 33 S8 p. S253-
1 p.
 artikel
269 Clinical significance of cranial nerve involvement. Base of skull erosion and intracranial extension in nasopharyngeal carcinomas Erkal, H.S.
 1997
 33 S8 p. S191-S192
2 p.
 artikel
270 Clinical significance of urokinase plasminogen activator and it receptor in breast cancer Duffy, M.J.
 1997
 33 S8 p. S195-
1 p.
 artikel
271 Clinical use of multi-segment intensity modulation A. Fraass, Benedick
 1997
 33 S8 p. S138-
1 p.
 artikel
272 Clinico-pathologlcal study of the adult Hodgkin's disease. 15-year experience, National Cancer Institute, Cairo, Egypt Saber, M.
 1997
 33 S8 p. S264-S265
2 p.
 artikel
273 Clips and scar as the guidelines for breast radiation boost after lumpectomy Kovner, F.
 1997
 33 S8 p. S107-
1 p.
 artikel
274 Clofazimlne and B4121 sensitize an intrinsically resistant human colon cancer cell line to paclitaxel and taxotere Jooné, G.
 1997
 33 S8 p. S179-
1 p.
 artikel
275 COLLATE: A collaborative authoring tool for the development of clinical oncology guideline Renaud-Salis, J.L.
 1997
 33 S8 p. S83-S84
2 p.
 artikel
276 Colorectal carcinoma — Intraoperative radiotherapy with Afterloading-Flab-Technique Tonus, C.
 1997
 33 S8 p. S107-
1 p.
 artikel
277 Colorectal liver metastases (CLM): Surgical or transcatheter treatment? Granov, A.M.
 1997
 33 S8 p. S171-
1 p.
 artikel
278 Colorectal surgery — How do I do it? Kremer, B.
 1997
 33 S8 p. S143-
1 p.
 artikel
279 Combinaiton bendamustin (B), mitomycin (M), 5-FU (FU) and prednisolon (P) in advanced gastrointestinal tumours with progress under chemotherapy Ridwelski, K.
 1997
 33 S8 p. S283-
1 p.
 artikel
280 Combination chemotherapy (CT) and secondary resection (SR) results in germ cell testicular cancer (TT) Cebotaru, C.
 1997
 33 S8 p. S44-
1 p.
 artikel
281 Combination of paclitaxel with mitoxantrone in patients with advanced breast cancer Ginopoulos, P.G.
 1997
 33 S8 p. S157-
1 p.
 artikel
282 Combined chemotherapy and radiation Jassem, J.
 1997
 33 S8 p. S286-S287
2 p.
 artikel
283 Combined chemotherapy-radiotherapy in I–II stage of non-Hodgkin's lymphomas Mustvatse, L.Z.
 1997
 33 S8 p. S270-
1 p.
 artikel
284 Combined effects of ionizing radiation and gemcitabine (GEM) in different cell lines Fleckenstein, K.
 1997
 33 S8 p. S27-
1 p.
 artikel
285 Combined effects of ionizing radiation and 4-hydroxy-ifosfamide (IFO) in different cell lines Latz, D.
 1997
 33 S8 p. S27-
1 p.
 artikel
286 Combined modality treatment and adjuvant lumbo-splenic radiotherapy (RT) in supra-diaphragmatic (SD) clinical stage (CS) I–II Hodgkin disease (HD) results in decreased rates of infra-diaphragmatic (ID) nodal relapses (R) Yilmaz, U.
 1997
 33 S8 p. S271-
1 p.
 artikel
287 Combined preoperative radiochemotherapy for non-small cell lung cancer (NSCLC) stage III UICC Rübe, Ch.
 1997
 33 S8 p. S235-
1 p.
 artikel
288 Combined therapy for advanced thymoma Isla, D.
 1997
 33 S8 p. S274-
1 p.
 artikel
289 Combined therapy of amifostine and gemcltabine in high-risk myelodysplastic syndromes Sezer, O.
 1997
 33 S8 p. S96-
1 p.
 artikel
290 Combined treatment modalities in oesophageal cancer Bosset, Jean Fancois
 1997
 33 S8 p. S292-
1 p.
 artikel
291 Combretastatin A-4, an agent that displays selective toxicity towards tumour vasculature Chaplin, D.
 1997
 33 S8 p. S44-
1 p.
 artikel
292 Communication between patient and radiotherapist prior to pailiative treatment Verhaak, C.
 1997
 33 S8 p. S59-
1 p.
 artikel
293 Comparative estimation of local control in radiotherapy supraglottic and glottic cancer Goleń, M.
 1997
 33 S8 p. S185-
1 p.
 artikel
294 Comparative study of imipenem versus sulperazone plus amikacin in febrile neutropenia Dinçol, D.
 1997
 33 S8 p. S58-
1 p.
 artikel
295 Comparative study of intravesical instillation of epirubicin, BCG, or BCG + INH in intermediate and high risk pTa-pT1 papillary carcinoma of the urinary bladder. First results of EORTC 30911 Meijden, A.v.d.
 1997
 33 S8 p. S138-
1 p.
 artikel
296 Comparison of the in vitro cytotoxicity of the antitumour antibiotics bleomycin and mitomycin on human colorectal cancer cells and endothelial cells Dirix, L.
 1997
 33 S8 p. S47-
1 p.
 artikel
297 Comparison of two conditioning regimens in allogeneic bone marrow transplantation (ABMT): Emphasis on the role of total body irradiation (TBI) for “high risk” patients Giraud, Ph.
 1997
 33 S8 p. S97-
1 p.
 artikel
298 Comparison of two systems for stem cell movilization (G-CSF ± chemotherapy) in breast cancer patients Isla, D.
 1997
 33 S8 p. S93-
1 p.
 artikel
299 Comparison of two types of central venous catheter (CVC) in a population of patients with bone sarcoma Loro, L.
 1997
 33 S8 p. S330-
1 p.
 artikel
300 Complementary therapies and cancer care McNamara, P.
 1997
 33 S8 p. S318-
1 p.
 artikel
301 Complications in the surgical treatment of carotid body paragangliomas Plukker, J.Th.M.
 1997
 33 S8 p. S254-S255
2 p.
 artikel
302 Complications rate following neutron or mixed beam irradiation for patients with head and neck malignancies Aref, A.
 1997
 33 S8 p. S189-
1 p.
 artikel
303 Compounds inhibiting angiogenesis Dirix, L.Y.
 1997
 33 S8 p. S218-S219
2 p.
 artikel
304 Computed tomography (CT-)Based treatment planning in prostate cancer Slotman, B.J.
 1997
 33 S8 p. S100-
1 p.
 artikel
305 Computer-assisted optimization of pancreatic treatment Ezzell, Gary
 1997
 33 S8 p. S277-
1 p.
 artikel
306 Computerized analysis of angiogenesis (CD31) in invasive cervical carcinoma: Multivariate analysis Tialma, W.
 1997
 33 S8 p. S50-
1 p.
 artikel
307 Concomitant chemoradiotherapy (CCR) for brain metastasis. Results of a phase I–II study Mahjoubi, R.
 1997
 33 S8 p. S201-
1 p.
 artikel
308 Concomitant radiochemotherapy with or without surgery in poor pronostic cervical cancer: A pilot study Muracciole, X.
 1997
 33 S8 p. S212-
1 p.
 artikel
309 Concurrent chema-radiotherapy for epidermoid anal cancer treatment Santoro, A.
 1997
 33 S8 p. S281-
1 p.
 artikel
310 Conformal radiation therapy for retinoblastoma: Comparison of various 3d proton plans Krengli, M.
 1997
 33 S8 p. S99-
1 p.
 artikel
311 Conformal radiotherapy of prostate cancer Lebesque, J.V.
 1997
 33 S8 p. S68-
1 p.
 artikel
312 Consent to medical treatment. What are the implications for nurses? Owen, J.
 1997
 33 S8 p. S332-
1 p.
 artikel
313 Conservative endbronchial treatment of non-small cell lung cancer Cicènas, S.
 1997
 33 S8 p. S237-
1 p.
 artikel
314 Conservative possibilities of treatment in sarcoma of the limbs lonescu, Th.
 1997
 33 S8 p. S113-
1 p.
 artikel
315 Conservative treatment of breast cancer: When, how, and who? Fourquet, A.
 1997
 33 S8 p. S143-
1 p.
 artikel
316 Consistent safety and efficacy results in 2 study populations treated with irinotecan (CPT-11) for metastatic colorectal cancer (MCRC) resistant to 5-FU Guimbaud, R.
 1997
 33 S8 p. S165-
1 p.
 artikel
317 Continous in vivo measurement of local mitochondrial metabolism after radiation Plasswilm, L.
 1997
 33 S8 p. S28-
1 p.
 artikel
318 Continuous 120 hours-infusion of mitomycin C (MMC) as salvage treatment in progressive or rapidly recurrent gastric cancer Hartmann, J.T.
 1997
 33 S8 p. S278-
1 p.
 artikel
319 Continuous infusion of Tramadol in dying cancer patients: Our preliminary data Tassinari, D.
 1997
 33 S8 p. S59-
1 p.
 artikel
320 Contralateral breast cancer and distant metastases Scepanovic, D.
 1997
 33 S8 p. S159-
1 p.
 artikel
321 Contribution of chemotherapy (CMT) to the survival (S) of patients (P) with advanced gastric cancer (AGC). A retrospective comparative study of patients who received and those who refused treatment (Tx) Tsavaris, N.
 1997
 33 S8 p. S282-
1 p.
 artikel
322 Control of acute cisplatin-induced nausea and emesis using a once daily oral treatment regimen of ondansetron plus dexamethasone Krzakowski, M.
 1997
 33 S8 p. S19-
1 p.
 artikel
323 Controversies in brachytherapy for localised prostate cancer Ash, D.
 1997
 33 S8 p. S6-
1 p.
 artikel
324 Conventional-dosage of Adriamycin and Paclitaxel vs. High-dose-chemotherapy with Cyclophosphamide, Mitoxantrone and VP-16 in the treatment of metastatic breast cancer — A randomized study Dingeldein, G.
 1997
 33 S8 p. S153-
1 p.
 artikel
325 Cooperative study of soft tissue sarcoma: First results Brodowicz, T.
 1997
 33 S8 p. S115-
1 p.
 artikel
326 Coping effectiveness in patients on chemotherapy for metastatic cancer Zabalegul, Adelalda
 1997
 33 S8 p. S301-
1 p.
 artikel
327 Correlation between BCL-2 expression and ex vivo chemosensitivity of advanced gynecologic cancers Landsberg, D.
 1997
 33 S8 p. S176-
1 p.
 artikel
328 Correlation between PSA, post-treatment biopsy and clinical outcome in irradiated prostate cancer patients Landmann, C.
 1997
 33 S8 p. S32-
1 p.
 artikel
329 Correlation between the number of CD34+ cells reinfused and complications and mortality of high-dose chemotherapy with stem cell support Alonso, M.
 1997
 33 S8 p. S92-
1 p.
 artikel
330 Correlation between the urinary DPD-crosslinks excretion and the course of bone metastases in breast cancer Lüftner, D.
 1997
 33 S8 p. S159-
1 p.
 artikel
331 Correlation between weight loss and appetite profile in cancer patients Arends, J.
 1997
 33 S8 p. S54-S55
2 p.
 artikel
332 Corticosteroid in acute vomiting — The more the better? Münstedt, K.
 1997
 33 S8 p. S52-S53
2 p.
 artikel
333 Cost-effectiveness in T1N0 glottic squamous cell carcinomas (SCC): Comparison between radiotherapy (RT), laser microsurgery (L) and partial laryngectomy (PL) Grégoire, V.
 1997
 33 S8 p. S253-S254
2 p.
 artikel
334 Counselling to help people with gynecologic cancer to adjust to their illness Vāisänen, L.
 1997
 33 S8 p. S322-
1 p.
 artikel
335 CPT11 alternating with 5 fluorouracil (5 FU) folinic acid (FA): A multicentre phase II study in 1st line chemotherapy (CT) of metastatic colorectal cancer (CRC): Preliminary results Barone, C.
 1997
 33 S8 p. S169-S170
2 p.
 artikel
336 C reactive protein and albumin in pancreatic cancer Pugliese, P.
 1997
 33 S8 p. S282-
1 p.
 artikel
337 “Cured of testicular cancer — Then what?”. A pilot study describing issues of sexuality and self-concept among survivors of testicular cancer Nielsen, P.V.
 1997
 33 S8 p. S322-
1 p.
 artikel
338 Current developments in the treatment of chronic myeloid leukemia Cornelissen, J.J.
 1997
 33 S8 p. S226-
1 p.
 artikel
339 Current position of cytokines in the clinical onology of solidtumours Fossá, Sophie D.
 1997
 33 S8 p. S144-
1 p.
 artikel
340 Current practice in early breast cancer post-operative irradiation: An italian survey Valdagni, R.
 1997
 33 S8 p. S101-
1 p.
 artikel
341 Current status and treatment of endometrial cancer Pecorelli, S.
 1997
 33 S8 p. S77-
1 p.
 artikel
342 Cyclic concomitant chemo-radiotherapy for limited small cell lung cancer Rebischung, J.-L.
 1997
 33 S8 p. S242-
1 p.
 artikel
343 Cyclic patterns of incidence variations for breast cancer: A hypothesis for heliophysical imprinting Dimitrov, B.D.
 1997
 33 S8 p. S130-S131
2 p.
 artikel
344 Cyclin-D1-expression of oral squamous carcinoma in comparison to precancerous lesions and normal oral mucosa Dammer, R.
 1997
 33 S8 p. S186-
1 p.
 artikel
345 Cyclosporin a in the treatment of myelodysplastic syndromes (MDS) Shirin, A.D.
 1997
 33 S8 p. S95-
1 p.
 artikel
346 Cyotokines and surrogate markers in HIV-related opportunistic malignancies Torresin, A.
 1997
 33 S8 p. S46-
1 p.
 artikel
347 Cytogenetic abnormalities involving both arms of chromosome 11 in metastatic effusions of 5 patients with breast or ovarian cancer Liosi, A.
 1997
 33 S8 p. S234-
1 p.
 artikel
348 Cytological grading of breast carcinoma Jovičić Milentijević, M.
 1997
 33 S8 p. S196-
1 p.
 artikel
349 Cytoplasmic transduction mechanisms of mitogenic signal Giuseppe Pelicci, Pier
 1997
 33 S8 p. S223-
1 p.
 artikel
350 Cytosine Deaminase — A suicide system for tumor therapy Haack, K.
 1997
 33 S8 p. S87-
1 p.
 artikel
351 Dacarbazine and tamoxifen in patients with advanced melanoma: An effective therapy option? Rass, K.
 1997
 33 S8 p. S258-S259
2 p.
 artikel
352 De-O-acetylation of adhesion molecule sialyl-LE× correlates with colorectal carcinoma progression Mann, B.
 1997
 33 S8 p. S165-
1 p.
 artikel
353 Describing patients' normal tissue reactions: A necessity for development of predictive testing of normal tissue radiosensitivity Bumet, N.G.
 1997
 33 S8 p. S23-
1 p.
 artikel
354 Design and regulations of clinical trials Therasse, P.
 1997
 33 S8 p. S77-
1 p.
 artikel
355 Design of an antisense oligonucleotide strategy to investigate the mode of action of the multidrug resistance-associated protein Cochrane, G.
 1997
 33 S8 p. S175-
1 p.
 artikel
356 Desmold tumors in children Kovalyov, A.I.
 1997
 33 S8 p. S125-S126
2 p.
 artikel
357 Detection and typing of human papillomavirus type 6/11, 16 and 18 infection in squamous cell carcinoma of uterine cervix in Taiwan Han, C.P.
 1997
 33 S8 p. S212-
1 p.
 artikel
358 Detection of cell surface sialylation of head and neck carcinomas by a new histobiochemical method Riedel, F.
 1997
 33 S8 p. S189-
1 p.
 artikel
359 Detection of circulating vascular endothelial growth factor (VEGF).matrix metalloprotelnase-3(MMP-3)and-9 (MMP-9) in gastrointestinal cancer Hyodo, I.
 1997
 33 S8 p. S46-
1 p.
 artikel
360 Detection of disseminated tumor cells in bone marrow of patients with resectable non-small cell lung cancer (NSCLC) — Long term results after 5 years of follow-up Passlick, B.
 1997
 33 S8 p. S227-
1 p.
 artikel
361 Detection of tumor progression in NSCLC stage IIIB/IV patients by serial measurement of CYFRA 21-1, TPA-M. TPS, and CEA Ebert, W.
 1997
 33 S8 p. S46-S47
2 p.
 artikel
362 Determination for the level of the breast examination knowledge between 15-49 years old married women which are being done by themselve Bahar, Z.
 1997
 33 S8 p. S313-
1 p.
 artikel
363 Determination of changes of tissue-specific genes expression in human brain tumors Kavsan, V.
 1997
 33 S8 p. S46-
1 p.
 artikel
364 Determination of DNA damage in uranium miners Plappert, U.
 1997
 33 S8 p. S129-
1 p.
 artikel
365 Developing a model for evidence based practice within an acute cancer centre Williams, E.
 1997
 33 S8 p. S301-
1 p.
 artikel
366 Developing a psychoeducational programme for the management of fatigue in patients receiving chemotherapy Ream, E.
 1997
 33 S8 p. S311-
1 p.
 artikel
367 Development and validation of a quality of life questionnaire for men who have been cured of testicular cancer Nielsen, P.V.
 1997
 33 S8 p. S300-
1 p.
 artikel
368 Development of a “myeloma risk score” for patients with a paraproteinaemia Ong, F.
 1997
 33 S8 p. S91-S92
2 p.
 artikel
369 Development of a solid foundation on which to build the future of cancer care on a remote Scottish Island with limited resources, both financial and human Bleakley, Grace
 1997
 33 S8 p. S333-S334
2 p.
 artikel
370 Developments in systemic therapy of pancreatic cancer Tempero, M.
 1997
 33 S8 p. S137-
1 p.
 artikel
371 Diagnostic and prognostic significance of protein patterns in human epithelial cancer Reymond, M.A.
 1997
 33 S8 p. S168-
1 p.
 artikel
372 Differences in cell proliferation fraction masked by apoptotic fraction in childhood lymphoma (MNHL) Ball, Lynne M.
 1997
 33 S8 p. S263-
1 p.
 artikel
373 Differences in photosensitiser induced fluorescence of rat adrenal chromaffin cells and pheochromocytoma cells (PC 12) Colombo-Benkmann, M.
 1997
 33 S8 p. S271-
1 p.
 artikel
374 Differences in the expression of epidermal growth factor receptor in lymph node metastases and primary tumors of the head and neck Baker-Schreye, A.
 1997
 33 S8 p. S184-
1 p.
 artikel
375 Differential expression of mRNA in squamous cell carcinoma of the head and neck Gottschlich, S.
 1997
 33 S8 p. S185-
1 p.
 artikel
376 Differential expression of VEGF in gastrointestinal tumors Strik, M.W.
 1997
 33 S8 p. S48-
1 p.
 artikel
377 Differential transcriptional regulation of the human gene for the M1 subunit of ribonucleotide reductase by p53 Baba, A.A.
 1997
 33 S8 p. S13-
1 p.
 artikel
378 Differentiation patterns of secondary skin fibroblasts from radiotherapy patients with different degrees of radiation-induced skin fibrosis Herskind, C.
 1997
 33 S8 p. S98-
1 p.
 artikel
379 Differing percentages of p53 gene mutations, correlation of p53 protein with point mutations and genetic instability in right and left colon cancer LLeonart, M.
 1997
 33 S8 p. S163-
1 p.
 artikel
380 Distinct patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung Petersen, I.
 1997
 33 S8 p. S227-
1 p.
 artikel
381 Distress and need for psychosocial support in cancer patients during radiotherapy DeVries, A.
 1997
 33 S8 p. S64-
1 p.
 artikel
382 D-lysine for reduction of renal[in-111-DTPA,D-phe-1 ]-octreotide and [Y-90-DOTA,D-phe-1,tyr-3]octreotide uptake de Jong, Marion
 1997
 33 S8 p. S16-
1 p.
 artikel
383 DNA alkylation and interstrand crosslinking by treosulfan hartley, J.A.
 1997
 33 S8 p. S177-
1 p.
 artikel
384 DNA damage assays predict normal tissue radiosensitivity Orton, C.J.
 1997
 33 S8 p. S23-
1 p.
 artikel
385 DNA damage in blood lymphocytes of former uranium miners Vahrenholz, C.
 1997
 33 S8 p. S14-
1 p.
 artikel
386 DNA damage responses in cells derived from breast cancer patients displaying radiosensitivity Jongmans, Wim
 1997
 33 S8 p. S65-
1 p.
 artikel
387 DNA in-situ hybridisation for the detection of apoptosis specific DNA fragments (Frag-EL) in routine endometrial curettage specimens Persad, V.
 1997
 33 S8 p. S204-
1 p.
 artikel
388 DNA mismatch repair deficient tumors exhibit length variability of repetitive DNA sequences in diverse promoter regions Sutter, C.
 1997
 33 S8 p. S11-
1 p.
 artikel
389 Docetaxel and cisplatin (DC) combination chemotherapy for metastatic urothelial cancer Dimopoulos, M.
 1997
 33 S8 p. S35-
1 p.
 artikel
390 Docetaxel (D) in combination with amifostine (A) in metastatic breast cancer (MBC): A feasibility and pharmacoklnetlc study of the EORTC-investigational drug branch for breast cancer (IDBBC) Awada, A.
 1997
 33 S8 p. S159-
1 p.
 artikel
391 Does caring for dying patients influence the dreams & nightmares experienced by healthcare workers? Roberts, A.
 1997
 33 S8 p. S308-
1 p.
 artikel
392 Does education assist cancer nurses with their fear of death? Willkinson, S.
 1997
 33 S8 p. S308-
1 p.
 artikel
393 Does polychemotherapy with dacarbazine, vindesine and clsplatin represent a useful therapeutic alternative in patients with advanced melanoma? Seiler, S.
 1997
 33 S8 p. S259-
1 p.
 artikel
394 Does poor management of side effects compromise treatment outcome? An oncologists view Harper, P.
 1997
 33 S8 p. S72-
1 p.
 artikel
395 Does the choice of anti-emetic alter the chemotherapy naive patient's psychological and physical well-being? Chadwick, Gill
 1997
 33 S8 p. S302-
1 p.
 artikel
396 Does your personality effect how you communicate with cancer patients? Wilkingson, S.
 1997
 33 S8 p. S74-
1 p.
 artikel
397 Do most of endometrial cancers arise from adenomatous hyperplasia? Hasumi, K.
 1997
 33 S8 p. S213-
1 p.
 artikel
398 Do nursing models have a place in cancer nursing? Sennenwald Etzel, B.
 1997
 33 S8 p. S326-
1 p.
 artikel
399 Do patients want the same information as their GP’s? Kaminski, E.
 1997
 33 S8 p. S311-
1 p.
 artikel
400 Dose escalation in accelerated hyperfractionation for advanced head and neck cancer El-Hadded, S.
 1997
 33 S8 p. S192-
1 p.
 artikel
401 Dose escalation of paclitaxel in combination with cyclophosphamide, thiotepa and carboplatin with stem cell rescue Yubero, A.
 1997
 33 S8 p. S93-
1 p.
 artikel
402 Dose finding and pharmacokinetic (PK) study of daily oral Idarubicin (IDA) in metastatic breast cancer (MBC) Sorio, R.
 1997
 33 S8 p. S251-
1 p.
 artikel
403 Dose finding study of high-dose eplrubicln (E) and docetaxel (T) as first line chemotherapy in advanced breast cancer (ABC) Pagani, O.
 1997
 33 S8 p. S147-
1 p.
 artikel
404 Dose-intensified versus standard chemotherapy in high-risk breast cancer patients: Preliminary data of a randomized trial Thomssen, C.
 1997
 33 S8 p. S149-
1 p.
 artikel
405 Dose response in primary ovarian cancer evaluated by an ex vivo ATP chemosensitivity assay Kurbacher, C.M.
 1997
 33 S8 p. S121-
1 p.
 artikel
406 Dose scheduling & drug tolerability in phase II studies of gemcitabine and cisplstin chemotherapy for non-small cell lung cancer Abratt, R.P.
 1997
 33 S8 p. S236-S237
2 p.
 artikel
407 Dosimetry in vivo in radiotherapy of head and neck cancer patients Miszczyk, L.
 1997
 33 S8 p. S99-
1 p.
 artikel
408 Double biochemical modulation of cisplatin, leucovorin and 5-fluorouracil in advanced gastric cancer Lopez, R.
 1997
 33 S8 p. S279-
1 p.
 artikel
409 Double-blind randomised trial of 105AD7 vaccine Durrant, L.G.
 1997
 33 S8 p. S85-
1 p.
 artikel
410 Drug-DNA interactions and extracellular metabolism of KW-2149: A novel mitomycin C analogue activated in serum McAdam, S.R.
 1997
 33 S8 p. S176-
1 p.
 artikel
411 Drug utilization for prevention of chemotherapy (CT)-induced emesis Roila, F.
 1997
 33 S8 p. S19-
1 p.
 artikel
412 Ductal carcinoma in situ of the breast, an evaluation of a new histopathological classification system Wämberg, F.
 1997
 33 S8 p. S195-
1 p.
 artikel
413 Early outcome of radiation treatment for clinically-localised prostate cancer Millar, J.L.
 1997
 33 S8 p. S35-
1 p.
 artikel
414 Early postoperative intraperitoneal chemo-immunotherapy after curative gastrectomy for stomach cancer Skvortsova, I.
 1997
 33 S8 p. S277-
1 p.
 artikel
415 Early stage testicular seminoma — A prospective multicenter trial Classen, J.
 1997
 33 S8 p. S37-
1 p.
 artikel
416 ECG and blood pressure changes during the 6-hours paclitaxel infusion Saip, P.
 1997
 33 S8 p. S56-
1 p.
 artikel
417 Economic costs of high-close chemotherapy with peripheral blood stem cell rescue Isla, D.
 1997
 33 S8 p. S95-
1 p.
 artikel
418 Effectiveness of antiemetic drugs in prevention of chemotherapy (CT)-induced acute emesis De Angelis, V.
 1997
 33 S8 p. S17-
1 p.
 artikel
419 Effect of amifostine (Ethyol®) on vascular density of the area vasculosa of chick embryo Hanjalic, A.
 1997
 33 S8 p. S50-
1 p.
 artikel
420 Effect of chemotherapy with 5-fluorouracil on intestinal permeability of patients with advanced colon cancer Daniele, B.
 1997
 33 S8 p. S169-
1 p.
 artikel
421 Effect of E2F-1 and E2F-1-mutants on the cellular survival and radiosensitivity Pruschy, M.
 1997
 33 S8 p. S22-
1 p.
 artikel
422 Effect of 5-fluorouracll (5-FU) infusion in myocardial perfusion scans Bishiniotic, T.
 1997
 33 S8 p. S17-
1 p.
 artikel
423 Effect of food on the pharmacokinetics of toremifene Anttila, M.
 1997
 33 S8 p. S253-
1 p.
 artikel
424 Effect of hypoxia on tumour growth and metastasis formation studied in chick embryo Höper, J.
 1997
 33 S8 p. S28-
1 p.
 artikel
425 Effect of β-interferon on vascular density, local metabolism and alkaline phosphatase activity in normoxla and hypoxia Demir, R.
 1997
 33 S8 p. S182-
1 p.
 artikel
426 Effect of ionizing radiation on cell-cycle progression as an expression of intrinsic radiosensitivity Bujor, L.
 1997
 33 S8 p. S28-
1 p.
 artikel
427 Effect of irradiation on microvessel density and endothelial cell proliferation in vivo Plasswilm, L.
 1997
 33 S8 p. S48-
1 p.
 artikel
428 Effect of radiation in radiotherapy treatments of laryngeal carcinoma: Clinical manifestation Costinescu, Luminita
 1997
 33 S8 p. S194-
1 p.
 artikel
429 Effect of the perioperative selective bowel decontamination in abdomlnothoracal resections of the esophagus Riedl, St.
 1997
 33 S8 p. S20-
1 p.
 artikel
430 Effects of an instruction card about diarrhea on the self-care knowledge — Behavior and symptom distress of patients receiving pelvic radiation therapy Coudyzer, W.
 1997
 33 S8 p. S310-
1 p.
 artikel
431 Effects of an instruction card about fatigue on the self-care knowledge, -behavlor and symptom distress of patients receiving cephalic, thoracic and pelvic radiation therapy Giesberts, K.
 1997
 33 S8 p. S311-
1 p.
 artikel
432 Effects of fractionation and dose rate in PDR-brachytherapy (PDR-BT) of B14-fibroblasts Keilholz, L.
 1997
 33 S8 p. S25-
1 p.
 artikel
433 Effects of hypuslnylatin of elF-5a on cell cycle progressionand specific mRNA translation in human tumor cells Koch, I.
 1997
 33 S8 p. S13-
1 p.
 artikel
434 Effects of MTA(multi-targeted antifolate, LY231514) on intracellular folate and nucleoside triphosphate pools in CCRF-CEM cells Chen, V.J.
 1997
 33 S8 p. S179-
1 p.
 artikel
435 Efficacy and safety of oral granisetron vs IV ondansetron in prevention of moderately emetogenic chemotherapy-induced nausea and vomiting Perez, E.A.
 1997
 33 S8 p. S18-
1 p.
 artikel
436 Efficacy of a combination of irinotecan (CPT-11) with mitomycin-C (MMC) for clear cell carcinoma of the ovary (OCCA) which is intrinsically platinum-resistant Shimizu, Y.
 1997
 33 S8 p. S119-
1 p.
 artikel
437 Efficacy of antibody treatment with 17/1A on reduction of MRD after completion of high dose chemotherapy with transplan-tation of in vitro tumor cell purged PBSC grafts in high risk breast cancer patients Hempel, D.
 1997
 33 S8 p. S151-S152
2 p.
 artikel
438 Efficacy of intrahepatic chemotherapy for liver metastases of rare gastrointestinal tract and other rare cancers Leder, G.H.
 1997
 33 S8 p. S282-
1 p.
 artikel
439 Efficacy of supplementary treatment with isotretinoin combined with interferon-alpha-2a in primary radiotherapy of cervical cancer — Results of a clinical phase-II-study Köhler, U.
 1997
 33 S8 p. S206-
1 p.
 artikel
440 EIB gene defective adenoviruses as an antitumor treatment in human cancer Martin Duque, P.
 1997
 33 S8 p. S86-
1 p.
 artikel
441 Electron beam portal imaging for routine documentation in radiation therapy Niehoff, P.
 1997
 33 S8 p. S103-
1 p.
 artikel
442 Electronic portal imaging in the detection of setup variation in daily treatment of patients undergoing radiation treatment for prostate cancer Millar, J.L.
 1997
 33 S8 p. S105-
1 p.
 artikel
443 ELFE (etoposide, folinic acid, 5-fluorouracil, and epirubicin) regimen in the treatment of advanced pancreatic cancer (APC) Maiello, E.
 1997
 33 S8 p. S280-S281
2 p.
 artikel
444 Employment of the mdr1 promoter for a conditionally active retroviral vector system in cancer gene therapy Walther, W.
 1997
 33 S8 p. S87-
1 p.
 artikel
445 Empowering communites, patients, and families through information Haylock, P.J.
 1997
 33 S8 p. S58-
1 p.
 artikel
446 Endocrine effects of toremifene (TOR) at the level of CNS in advanced breast cancer patients Számel, I.
 1997
 33 S8 p. S154-
1 p.
 artikel
447 Endocrine treatment in advanced breast cancer Mouridsen, H.T.
 1997
 33 S8 p. S216-
1 p.
 artikel
448 Endometrial carcinoma (EC) in women with breast cancer (BC) Mignotle, H.
 1997
 33 S8 p. S205-
1 p.
 artikel
449 Enhancement of radiation response of Dunning R3327 prostatic adenocarcinoma by IL-2 and histamine Johansson, S.
 1997
 33 S8 p. S32-
1 p.
 artikel
450 Enhancing patient care: The role of a lymphoma clinical nurse specialist in the UK Goode, V.J.
 1997
 33 S8 p. S329-
1 p.
 artikel
451 Entry to breast cancer clinical trials: The importance of specialist treatment team Twelves, C.J.
 1997
 33 S8 p. S81-
1 p.
 artikel
452 Environmental epidemiology of childhood cancer Zaridze, D.
 1997
 33 S8 p. S78-
1 p.
 artikel
453 Epidemiology and screening of colorectal cancer Faivre, J.
 1997
 33 S8 p. S217-
1 p.
 artikel
454 Epidemiology of cancer in Europe — What are the trends? Boyle, P.
 1997
 33 S8 p. S5-
1 p.
 artikel
455 Epidemiology of non-Hodgkin's lymphoma in Occidental Canary Islands Llanos, M.
 1997
 33 S8 p. S267-
1 p.
 artikel
456 Epithelial cells in the bone marrow (BM) of colorectal carcinoma (CRC) patients: A tool to monitor immunotherapy? Liljefors, M.
 1997
 33 S8 p. S89-
1 p.
 artikel
457 Eradication of chemoresistant ovarian cancer in combination with gene and cytotoxical therapy Giannios, John
 1997
 33 S8 p. S85-
1 p.
 artikel
458 Eroding the boundaries: Improving the interface between hospital and community palliative care services Ablett-Spence, Ingrid
 1997
 33 S8 p. S309-
1 p.
 artikel
459 Essential factors in hyperthermic isolated limb perfusion (HILP) — Experimental results of in-vitro and in-vivo studies Meyer, Th.
 1997
 33 S8 p. S257-
1 p.
 artikel
460 ESSO award lecture: The challenge of quality assurance in surgical oncology Mattheiem, Wolrad H.
 1997
 33 S8 p. S214-
1 p.
 artikel
461 Estereotactic, linear acelerator based radiosurgery for brain metastases Rodríguez Villalba, S.
 1997
 33 S8 p. S202-
1 p.
 artikel
462 Estereotactic radiosurgery for single brain metastases Santos Ortega, M.
 1997
 33 S8 p. S201-
1 p.
 artikel
463 Estimation of the influence of biological modyfires on severity of acute mucosal reaction in patients with head and neck cancer Pilecki, B.
 1997
 33 S8 p. S190-
1 p.
 artikel
464 Ethical dilemma's in the care of cancer patients Willems, Y.
 1997
 33 S8 p. S306-
1 p.
 artikel
465 Etoposide, leucovorin and fluorouracil (ELF) in advanced gastric cancer: Our experience Scimone, A.
 1997
 33 S8 p. S283-
1 p.
 artikel
466 Europath: A European network supporting communication and database resources in oncopathology Brugal, G.
 1997
 33 S8 p. S284-
1 p.
 artikel
467 Euthanasia extension of life vs quality of life Elhanani, Hedva
 1997
 33 S8 p. S334-
1 p.
 artikel
468 Evaluating the process of nursing care: The development and implementation of a modular system Loonstra, K.S.
 1997
 33 S8 p. S320-S321
2 p.
 artikel
469 Evaluation nursing care in neutropenic patients with basic measures of isolations Salazar, R.N.
 1997
 33 S8 p. S300-
1 p.
 artikel
470 Evaluation of a standard for emotional support for outpatients in a regional cancer centre in the UK Pratt, J.
 1997
 33 S8 p. S312-
1 p.
 artikel
471 Evaluation of body composition in patients with lung cancer by bioelectric impedance (BIA) Toso, S.
 1997
 33 S8 p. S58-S59
2 p.
 artikel
472 Evaluation of catering services and introduction of a cook freeze meal system at a regional oncology unit in the United Kingdom Lees, J.
 1997
 33 S8 p. S323-
1 p.
 artikel
473 Evaluation of minimal and residual disease (MRD) in Ewing's tumors (ET) at diagnosis and during treatment Fagnou, C.
 1997
 33 S8 p. S126-S127
2 p.
 artikel
474 Evaluation of residual or recurrent malignant lymphoma by FDG-PET Sökler, M.
 1997
 33 S8 p. S263-
1 p.
 artikel
475 Evaluation of the role of a single cycle of carboplatin as an adjuvant treatment in stage I seminoma and as a neo-adjuvant prior to radiotherapy in stage II Faris, M.
 1997
 33 S8 p. S43-
1 p.
 artikel
476 Evidence based cancer nursing practice: Does it exist? Giulio, Paola Di
 1997
 33 S8 p. S297-
1 p.
 artikel
477 Evidence-based medicine and the cochrane collaboration: A new approach to medical decision-making in cancer therapy Rüther, A.
 1997
 33 S8 p. S130-
1 p.
 artikel
478 Evidenced based cancernursing practice Redmond, K.
 1997
 33 S8 p. S293-
1 p.
 artikel
479 Evidence for different site-related genetic mechanisms in the pathogenesis of sporadic colorectal cancer Cianchi, F.
 1997
 33 S8 p. S161-
1 p.
 artikel
480 Evidence for enhanced toxicity to CPT-11 in patients with Gilbert's syndrome: Two case reprots Wasserman, E.
 1997
 33 S8 p. S250-
1 p.
 artikel
481 Evidence of circulating tumor cells of Ewing's sarcoma is associated with higher incidence of local relapse and metastatic spread García-Foncillas, J.
 1997
 33 S8 p. S112-S113
2 p.
 artikel
482 Evidence of p53-independent activation of bcl-2 in advanced ovarian and endometrium carcinomas Gilster, T.J.
 1997
 33 S8 p. S122-S123
2 p.
 artikel
483 Evidence of work-induced stress among oncology clinical and non-clinical health care personnel in Glasgow and the West of Scotland Bindermann, S.
 1997
 33 S8 p. S75-
1 p.
 artikel
484 Evolution of biological parameter in patients with breast cancer treated with primary chemotherapy Donadio, M.
 1997
 33 S8 p. S198-S199
2 p.
 artikel
485 Ewing's sarcoma in childhood — The role of radiotherapy Costa, Maria Adelina
 1997
 33 S8 p. S109-
1 p.
 artikel
486 Examination of secretory phospholipase A2 (sPLA2) as a maker of metastasis Massing, U.
 1997
 33 S8 p. S47-S48
2 p.
 artikel
487 Experiences of mothers who are diagnosed with recurrent breast cancer Bumet, Karen
 1997
 33 S8 p. S320-
1 p.
 artikel
488 Experiences with thermoradiotherapy of locally recurrent breast cancer Hehr, T.
 1997
 33 S8 p. S154-S155
2 p.
 artikel
489 Exploiting hypoxia: Bioreductive drugs and gene therapy approache Stratford, Ian J.
 1997
 33 S8 p. S220-
1 p.
 artikel
490 Expression of bcl-2 protein in non-small cell lung carcinoma (NSCLC) Athanassiadou, P.
 1997
 33 S8 p. S231-
1 p.
 artikel
491 Expression of cripto-1, a new ligand of the EGF superfamily, in gynecological carcinomas Ebert, A.
 1997
 33 S8 p. S206-
1 p.
 artikel
492 Expression of matrix metalloproteinase 7 (MMP-7) in alimentary tracta cancer, lung cancer and breast cancer Konishi, J.
 1997
 33 S8 p. S49-
1 p.
 artikel
493 Expression of novel growth suppreslng gene, TOB, in patients with esophageal cancer Nonaka, Y.
 1997
 33 S8 p. S15-
1 p.
 artikel
494 Expression of p53 protein in endometrial carcinomas: Relationship with ER and PR status Athanassiades, P.
 1997
 33 S8 p. S15-
1 p.
 artikel
495 Expression of r-glutamylcysteine gene in human urothelial cancer: Relation to chemotherapy response Yang, Chi-Rei
 1997
 33 S8 p. S173-
1 p.
 artikel
496 Expression of soluble CD44 and splice variants VSand V6 and its implication in tumour staging according to the TNM classification in gastric cancer Kocik, J.
 1997
 33 S8 p. S48-
1 p.
 artikel
497 Expression of the β4 integrin subunit is closely related to hematogenous metastasis in gastric cancer Vielhaber, A.
 1997
 33 S8 p. S275-
1 p.
 artikel
498 Expression of the multidrug resistance-associated protein (MRP) and chemoresistance of human non-small-cell lung cancer cells Berger, W.
 1997
 33 S8 p. S181-
1 p.
 artikel
499 Extended field (EF) and total central lymphatic (TCl) radiotherapy for early stages nodal centroblastic-eentrocytic (CB-CC) lymphoma Stuschke, M.
 1997
 33 S8 p. S261-
1 p.
 artikel
500 Extended salivary response to ionizing irradiation: An experimental study Nagler, R.
 1997
 33 S8 p. S26-
1 p.
 artikel
501 Extending the role of the clinical nurse specialist in Medical Oncology/Haematology Fitzsimmons, L.
 1997
 33 S8 p. S329-
1 p.
 artikel
502 External beam radiation (EBRT) for retinoblastoma (RB): The Hospital Vall d’Hebron experience and review of literature Giralt, J.
 1997
 33 S8 p. S127-
1 p.
 artikel
503 External radiotherapy in macular degeneration: Our technique, dosimetric calculation and preliminary subjective response Akmansu, M.
 1997
 33 S8 p. S106-
1 p.
 artikel
504 Extremity soft tissue sarcomas Pitcher, M.E.
 1997
 33 S8 p. S115-S116
2 p.
 artikel
505 Facilitation of children's adjustment to the terminal illness and death of a parent due to cancer Hahn, D.
 1997
 33 S8 p. S339-
1 p.
 artikel
506 Factor predisposing to chronic pain after breast cancer treatment Tasmuth, T.
 1997
 33 S8 p. S197-
1 p.
 artikel
507 Factors determining late complications following postoperative radiotherapy in endometrial carcinoma Jereczek-Fossa, B.
 1997
 33 S8 p. S98-
1 p.
 artikel
508 Factors determining the appreciation of treatment by advanced colorectal cancer patients Breimer-Linckens, E.M.
 1997
 33 S8 p. S60-
1 p.
 artikel
509 Factors encouraging or discouraging women undergo clinical breast examination Barak, F.
 1997
 33 S8 p. S129-
1 p.
 artikel
510 Factors predicting response to chemo-endocrine treatment in advanced breast cancer Gieseking, F.
 1997
 33 S8 p. S155-
1 p.
 artikel
511 Families experience of bereavement in the oncological intensive care unit — A qualitative prospective study Dolan, S.
 1997
 33 S8 p. S320-
1 p.
 artikel
512 Fatigue in cancer patients Glaus, A.
 1997
 33 S8 p. S326-
1 p.
 artikel
513 Favorable outcome following early treatment intensification with ifosfamide for high-risk extremity osteosarcoma. Long term results of study COSS-86 Bielack, S.
 1997
 33 S8 p. S110-S111
2 p.
 artikel
514 Favourable prognosis after late relapse in Hodgkin's disease García-Carbonero, R.
 1997
 33 S8 p. S263-
1 p.
 artikel
515 Feasibility and phase II study of combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas Berns, T.
 1997
 33 S8 p. S277-
1 p.
 artikel
516 Fibroblast contamination in assays of tumour radio-sensitivity Stausbøl-Grøn, B.
 1997
 33 S8 p. S25-
1 p.
 artikel
517 Fibronectin is a prognostic factor in malignancy: An ultrastructural and immunofluorescence study of carcinoma of the bladder Yehia, H.A.
 1997
 33 S8 p. S34-
1 p.
 artikel
518 First demonstration of anti-lymphoma activity of BCL-2 antisense molecule-G3139; Results of phase I/IIA clinical trial Webb, A.
 1997
 33 S8 p. S261-
1 p.
 artikel
519 First line treatment of advanced non-small cell lung cancer with doxetaxel and cis-platin: A multicenter phase II study Androulakis, N.
 1997
 33 S8 p. S236-
1 p.
 artikel
520 FISH identifies different types of duplications with 12q13-15 as the commonly involved segment in B-eell lymphoproliferative malignancies characterized by partial trisomy 12 Dierlamm, J.
 1997
 33 S8 p. S264-
1 p.
 artikel
521 Fluorescent and immunocytochemical stalnlngs of primary urine derived cell cultures from patients with TCC Özdermir, E.
 1997
 33 S8 p. S31-S32
2 p.
 artikel
522 5-Fluorouracil abolishes cell cycle arrest and increases cytotoxicity by different mechanisms when added after cisplatin or X-irradiation Nylén, Urban D.
 1997
 33 S8 p. S26-S27
2 p.
 artikel
523 Focal expression of platelet-derlved endothelial cell growth factor (PD-ECGF)triggers local neo-angiogenesls in non-small cell lung cancer Giatromanolaki, A.
 1997
 33 S8 p. S44-S45
2 p.
 artikel
524 Focused ultrasound thermotherapy: A new promising tumor treatment principle Huber, P.
 1997
 33 S8 p. S104-
1 p.
 artikel
525 Formation of the regional register of hereditary breast cancer Terveschenko, I.V.
 1997
 33 S8 p. S131-
1 p.
 artikel
526 Founding BRCA1 mutations in Austrian HBOC families Wagner, T.
 1997
 33 S8 p. S7-
1 p.
 artikel
527 Four cycles of ABVD followed by involved field irradiation (IF-RT) is the treatment of choice for early-stage Hodgkin's disease (HD): 5-year results of a randomized trial Santoro, A.
 1997
 33 S8 p. S262-
1 p.
 artikel
528 Frequency and prognostic significance of genetic instability at tumour suppressor gene loci in mamary carcinomas Ryś, J.
 1997
 33 S8 p. S10-
1 p.
 artikel
529 Frequency domain laser scanning mammography of the breast — First clinical evaluation study Moesta, K.T.
 1997
 33 S8 p. S83-
1 p.
 artikel
530 Frequency of continuous cycling in childhood soft tissue sarcoma revealed by analysis of apoptotic fraction Ball, L.M.
 1997
 33 S8 p. S116-
1 p.
 artikel
531 Frequent inactivation of the CDKN2 gene by methylation and deletion in breast carcinomas An, H.X.
 1997
 33 S8 p. S8-
1 p.
 artikel
532 Frontiers in the management of colorectal cancer — Combined modality treatment Glimelius, B.
 1997
 33 S8 p. S287-
1 p.
 artikel
533 Functional and proliferative characteristics of neovasculature as potential targets in tumour therapy Denekamp, J.
 1997
 33 S8 p. S224-
1 p.
 artikel
534 Functional and structural immunodefects after limited volume radiotherapy Belka, C.
 1997
 33 S8 p. S101-
1 p.
 artikel
535 Functional folate status as a prognostic indicator of toxicity in clinical trials of the multitargeted antifolate LY231514 Zervos, Peter H.
 1997
 33 S8 p. S18-
1 p.
 artikel
536 Gastric cancer: The value of limited lymph node dissection for early stage gastric cancer Izumi, S.
 1997
 33 S8 p. S276-
1 p.
 artikel
537 Gastro-oesophageal smooth muscle tumors: Treatment and analysis of prognostic factors Nijhuls, P.A.
 1997
 33 S8 p. S280-
1 p.
 artikel
538 Gel formula dressing in the care of acute skin damage by radiation in head and neck cancer patients Chen, Yu-Ping
 1997
 33 S8 p. S302-
1 p.
 artikel
539 Gemcitabine and cisplatin for advanced non-small cell lung cancer (NSCLC) Casal, J.
 1997
 33 S8 p. S239-
1 p.
 artikel
540 Gemcitabine and etoposide in chemonaive patients with extensive small cell lung cancer (SCLC): Preliminary phase II results Pawel, J.v.
 1997
 33 S8 p. S233-
1 p.
 artikel
541 Gemcitabine (GEM) and 5-fluorouracil (5 FU) in advanced pancreatic cancer: A GISCAD phase II study Cascinu, S.
 1997
 33 S8 p. S280-
1 p.
 artikel
542 Gemcitabine (GEM) — Cisplatin (COOP) — Vinorelbine (VNR) combination in advanced non-small-cell lung cancer (NSCLC). A phase II randomized study Comella, P.
 1997
 33 S8 p. S229-
1 p.
 artikel
543 Gemcitabine in advanced pancreatic cancer: A phase II trial Crinò, L.
 1997
 33 S8 p. S280-
1 p.
 artikel
544 Gender and age influence baseline quality of life (QL) assessments in cancer patients Dancey, J.
 1997
 33 S8 p. S59-
1 p.
 artikel
545 Generation and characterization of cytotoxic T lymphocytes (CTL) against mutated ras peptides Juretic, A.
 1997
 33 S8 p. S87-
1 p.
 artikel
546 Genes and the development of prostate cancer Maitland, N.J.
 1997
 33 S8 p. S68-
1 p.
 artikel
547 Gene therapy for melanoma Stingl, Georg
 1997
 33 S8 p. S135-
1 p.
 artikel
548 Genetically modified tumour vaccines: Transduction of IL-2 and CD80 gene Bubeník, J.
 1997
 33 S8 p. S136-
1 p.
 artikel
549 Genetic alterations in benign and borderline malignant breast tumors Dal Cin, P.
 1997
 33 S8 p. S7-
1 p.
 artikel
550 Genetic alterations in ductal carcinoma in situ of the breast: Association with histologic type van de Vijver, M.J.
 1997
 33 S8 p. S67-
1 p.
 artikel
551 Genetic analysis of famllal adenomatous polyposis (FAP) families: Lessons and implications Gebert, J.
 1997
 33 S8 p. S11-S12
2 p.
 artikel
552 Genetic and cytogenetic alterations in ovarian cancer Bauknecht, T.
 1997
 33 S8 p. S139-
1 p.
 artikel
553 Genetic determinants of radiosensitivity: Potential for therapeutic modulation Ross, Gillian M.
 1997
 33 S8 p. S70-
1 p.
 artikel
554 Genetic drug activation strategies for breast cancer Sikora, K.
 1997
 33 S8 p. S136-
1 p.
 artikel
555 Genetic predisposition to multiple cancers Bonaïti-Pellié, C.
 1997
 33 S8 p. S140-
1 p.
 artikel
556 Genetic susceptibility linked with rare HA-ras1 alleles and microsatellite alterations in non-small cell lung cancer (NSCLC) Rosell, R.
 1997
 33 S8 p. S286-
1 p.
 artikel
557 Genomic instability as assessed by micro satellite analysis in childhood rhabdomyosarcoma (RMS) Riddell, C.
 1997
 33 S8 p. S15-
1 p.
 artikel
558 Germ cell tumor (GCT): Staging and therapy control with 18FDG-PET. First results of German multicenter trial de Wit, M.
 1997
 33 S8 p. S38-
1 p.
 artikel
559 Germ cell tumors (GCT) in men with HIV infection Hentrich, M.
 1997
 33 S8 p. S41-
1 p.
 artikel
560 Germline mutations in the CDKN2 and CDK4 genes are rare in melanoma families in the UK Harland, M.
 1997
 33 S8 p. S12-
1 p.
 artikel
561 Growth factor activated MAP kinases: Mechanism of nuclear translocation and role in growth control Brunet, A.
 1997
 33 S8 p. S223-
1 p.
 artikel
562 Growth factors and ErbB/HER tyrosine kinases: How do they contribute to malignancy? Yarden, Yosef
 1997
 33 S8 p. S223-S224
2 p.
 artikel
563 Growth from child to adult — Interference by radiotherapy Voûte, P.A.
 1997
 33 S8 p. S140-S141
2 p.
 artikel
564 Growth pattern and development of metastasis in orthotopically transplanted human osteosarcoma xenografts in nude mice Cmalic, S.
 1997
 33 S8 p. S113-
1 p.
 artikel
565 Guidelines in the French system: Thee xperience of the Rhone Alpes Area and the French Federation of Cancer center SOR program Philip, T.
 1997
 33 S8 p. S293-
1 p.
 artikel
566 Gynaecological cancer: Advantages and possibilities of intraarterial polychemotherapy Vinnitskaya, A.
 1997
 33 S8 p. S211-
1 p.
 artikel
567 HDR-brachytherapy is an effective treatment modality in primary treatment of inoperable patients with endometrial carcinoma Knocke, T.H.
 1997
 33 S8 p. S207-
1 p.
 artikel
568 Health-related quality of life and sequelae in patients treated with external beam irradiation (EBI) and brachytherapy for localized prostate cancer (LPC) Joly, F.
 1997
 33 S8 p. S33-S34
2 p.
 artikel
569 Helicobacter pylori associated stomach cancer elicits specific germiline encoded IgM response Hensel, F.
 1997
 33 S8 p. S283-
1 p.
 artikel
570 Helicobacter pylori infection and gastric carcinoma Jovanović, D.M.
 1997
 33 S8 p. S281-
1 p.
 artikel
571 Helplessness reduction in a palliative care unit (PCU) Die Trill, M.
 1997
 33 S8 p. S221-
1 p.
 artikel
572 Hemoblastoses in Belarus: 10 years after Chernobyl. Do we have any radiation-elependent increase? Ivanov, V.E.
 1997
 33 S8 p. S131-
1 p.
 artikel
573 Hemoglobin levels predict local regional control after postoperative radiotherapy for advanced head and neck cancer Guttenberger, R.
 1997
 33 S8 p. S102-S103
2 p.
 artikel
574 Hereditary nonpolyposls colorectal cancer is preventable De la Chapelle, Albert
 1997
 33 S8 p. S217-
1 p.
 artikel
575 High-close chemotherapy (HDC) and autologous peripheral blood stem cell support (PBSC) in patients with metastatic breast cancer (MBC) Huober, J.
 1997
 33 S8 p. S95-
1 p.
 artikel
576 High correlation of the expression of p53 protein in synchronou head and neck and esophageal neoplasm Metges, J.P.
 1997
 33 S8 p. S50-
1 p.
 artikel
577 High dose chemotherapy and side effects Muñoz-Sanjuán, M.
 1997
 33 S8 p. S337-
1 p.
 artikel
578 High dose chemotherapy (HDCT) and side effects Colussi, A.M.
 1997
 33 S8 p. S337-
1 p.
 artikel
579 High dose cyclophosphamide (C) and eplrublcln (E) followed by clsplatln (P) and 5-fluoro-uraclle (F) in patients with advanced epithelial ovarian adenocarcinoma (AEOC) Braud, A.C.
 1997
 33 S8 p. S123-
1 p.
 artikel
580 High dose-density chemotherapy for small cell lung cancer (SCLC) Dómine, M.
 1997
 33 S8 p. S229-S230
2 p.
 artikel
581 High dose methotrexate (HDMTX) pharmacokinetic profile in osteosarcoma patients Comandone, A.
 1997
 33 S8 p. S249-
1 p.
 artikel
582 High-dose rate Interstitial brachytherapy followed by percutaneous irradiation for prostate cancer — First results of a prospective trial Wiegel, T.
 1997
 33 S8 p. S32-S33
2 p.
 artikel
583 High dose sequential (HDS) cyclophosphamide (C) and epirubicin (E) with peripheral blood stem cell (PBSC) for metastatic breast cancer (MBC): Promising results Cottu, P.H.
 1997
 33 S8 p. S156-
1 p.
 artikel
584 High-dose therapy with peripheral blood progenitor cell (PBPC) autografting in multiple myeloma (MM) Goldschmidt, H.
 1997
 33 S8 p. S92-
1 p.
 artikel
585 High-dose therapy with peripheral blood progenitor cell support (PBPC) for the treatment of advanced breast cancer Fersis, N.
 1997
 33 S8 p. S149-
1 p.
 artikel
586 High effectiveness of combined treatments of paclitaxel (TX) and 4'-epi-doxorubicln (EP) in a murine tumour: A preclinical study Cividalli, A.
 1997
 33 S8 p. S180-
1 p.
 artikel
587 High lysolipid activity in malignant effusions in ovarian cancer patients Westermann, A.M.
 1997
 33 S8 p. S121-
1 p.
 artikel
588 High precision conformal radiotherapy (RT) (HP-CRT)of patients with prostatic cancer Widmarkten, Anders
 1997
 33 S8 p. S31-
1 p.
 artikel
589 High resolution HLA-DRB1 genotyping in patients with RCC Özdemir, E.
 1997
 33 S8 p. S13-
1 p.
 artikel
590 Histopathological and biochemical evaluation of wound healing following preoperative irradiation, chemo-irradlatlon and intra-peritoneal 5-fluorouracll (5-FU) in the rat Juzu, M.A.
 1997
 33 S8 p. S103-S104
2 p.
 artikel
591 HLA genotype can be predictive for the breast cancer susceptibility and outcome Togo, Alexandr V.
 1997
 33 S8 p. S197-
1 p.
 artikel
592 Homeobox genes expression in endothelial cells and their potential role in angiogenesis Belotti, D.
 1997
 33 S8 p. S44-
1 p.
 artikel
593 Home sweet home! Home care technology for patients with cancer or serious infectious diseases van Boxte, A.J.H.
 1997
 33 S8 p. S327-
1 p.
 artikel
594 Hormonal effects of MPV-2213ad, a novel, competitive aromatase inhibitor in healthy male volunteers. A phase I study Ahokoski, O.
 1997
 33 S8 p. S250-
1 p.
 artikel
595 Hospital closed-circuit TV as an educational strategy to meet the learning needs of cancer patient Johow, V.
 1997
 33 S8 p. S310-
1 p.
 artikel
596 How could be estimate the satisfaction grade for nursing care in an oncologic centre? Tadini, L.
 1997
 33 S8 p. S335-
1 p.
 artikel
597 How does sex life affect or change a ca-patients life? Arendt, Christa
 1997
 33 S8 p. S322-
1 p.
 artikel
598 How effective are current treatments in the management of skin reactions induced by radiotherapy to the breast? Johnson, K.E.
 1997
 33 S8 p. S298-
1 p.
 artikel
599 How far should we go in treating cancer patients? Klastersky, J.
 1997
 33 S8 p. S222-
1 p.
 artikel
600 How should we assess alternative medicine? Smyth, John F.
 1997
 33 S8 p. S221-S222
2 p.
 artikel
601 How to perform effective IL-2 therapy Den Otter, Willem
 1997
 33 S8 p. S87-S88
2 p.
 artikel
602 How to tell cancer patients — A contribution to a theory of diagnosis-communication Salander, P.
 1997
 33 S8 p. S62-
1 p.
 artikel
603 4-hydroxyandrostenedione (4-OHA) as third-line endocrine therapy in postmenopausal patients with advanced breast cancer Gennatas, C.S.
 1997
 33 S8 p. S158-
1 p.
 artikel
604 Hyperfractionated accelerated radiotherapy for carcinoma of the oesophagus. 5 years follow-up Sulé-Suso, J.
 1997
 33 S8 p. S106-
1 p.
 artikel
605 Hyperthermic isolated limb perfusion (HILP) — A therapeutic concept in locoreglonal metastasized malignant melanoma — Experiences over 20 years Göhl, J.
 1997
 33 S8 p. S256-
1 p.
 artikel
606 Hyposalivation and white blood cells loss following head and neck irradiation and a mediatory role of superoxide dismutase Nagler, R.
 1997
 33 S8 p. S27-S28
2 p.
 artikel
607 Hypoxic modification in radiotherapy Overgaard, Jens
 1997
 33 S8 p. S219-S220
2 p.
 artikel
608 Idarubicin in advanced or relapsed multiple myeloma treatment in elderly Scassa, E.
 1997
 33 S8 p. S94-
1 p.
 artikel
609 IDEC-C2B8-induced B cell depletion is not associated with significant immune suppression or infection White, C.A.
 1997
 33 S8 p. S266-
1 p.
 artikel
610 Identifying tumour hypoxia Nordsmark, M.
 1997
 33 S8 p. S219-
1 p.
 artikel
611 Ifosfamide and Hexamethilmelamine as rescue treatment for cisplatin refractory ovarian cancer Torrecillas, L.
 1997
 33 S8 p. S122-
1 p.
 artikel
612 Ifosfamide (IFO) in continuous infusion (C.I.) for 21 days as second line therapy in advanced sarcomas: A phase I study Comandone, A.
 1997
 33 S8 p. S112-
1 p.
 artikel
613 Ifosfamide (IFO) in the treatment of metastatic hormone refractory prostate cancer Kellokumpu-Lehtinen, P.
 1997
 33 S8 p. S32-
1 p.
 artikel
614 Image resolution and geometric accuracy of digital reconstructed radiographs (DRR) in conventional and helical computed tomography Zimmermann, J.S.
 1997
 33 S8 p. S103-
1 p.
 artikel
615 Imaging processing for evaluation and reduction of geometrical uncertainties in prostate irradiation van Herk, M.
 1997
 33 S8 p. S137-
1 p.
 artikel
616 Immediate breast reconstruction in breast cancer Dixon, J.M.
 1997
 33 S8 p. S141-S142
2 p.
 artikel
617 Immediate hormonotherapy with an LHRH analogue improves local control and survival in patients with locally advanced prostate cancer treated by radiotherapy. A randomized phase III clinical trial of the EORTC Bolla, M.
 1997
 33 S8 p. S29-
1 p.
 artikel
618 Immediate results of the locally advanced larynx cancer T3–4N0–3M0 treatment using non-conventional dose fractionation radiotherapy Slobina, E.
 1997
 33 S8 p. S193-
1 p.
 artikel
619 Immediate versus delayed postprostatectomy irradiation Sagerman, R.H.
 1997
 33 S8 p. S30-
1 p.
 artikel
620 Immune responses to peptide-based cancer vaccines Jãger, E.
 1997
 33 S8 p. S289-
1 p.
 artikel
621 Immunization of melanoma patients with peptide-pulsed dendritic cells Schadendort, D.
 1997
 33 S8 p. S86-
1 p.
 artikel
622 Immuno-chemoembolisation in the treatment of colorectal livermetastasis Müller, H.
 1997
 33 S8 p. S164-
1 p.
 artikel
623 Immunochemotherapy (IC) in patients with metastatic renal cell carcinoma Samland, D.
 1997
 33 S8 p. S39-S40
2 p.
 artikel
624 Immunohistochemical analysis of integrin αvβ3 expression on tumor associated vessels of human carcinomas — Implications for anti-angiogenic treatment approaches Max, R.
 1997
 33 S8 p. S48-S49
2 p.
 artikel
625 Immunohlstochemlcally detected lymph node micrometastases (N1A-IHC) in breast cancer (BC) Gerber, B.
 1997
 33 S8 p. S196-
1 p.
 artikel
626 Immunoreactive detection of parathormone related protein (PTHrP) in primary breast cancer is a good prognostic factor for subsequent bone metastase Gollan, Ch.
 1997
 33 S8 p. S195-
1 p.
 artikel
627 Immunotherapy of advanced ovarian cancer with the anti-idiotypic antibody MAb ACA 125 — Results of a clinical phase IB study Wagner, U.
 1997
 33 S8 p. S118-
1 p.
 artikel
628 Impact of anatomical varlability on dose delivery by three field technique in adjuvant radiotherapy of breast cancer Vinh-Hung, V.
 1997
 33 S8 p. S107-S108
2 p.
 artikel
629 Implementing palliative care strategies in an acute cancer setting Madsen, Lisbet Due
 1997
 33 S8 p. S307-
1 p.
 artikel
630 Importance of surgery in the treatment of non-Hodgkin's lymphoma of the stomach Meyer, H.-J.
 1997
 33 S8 p. S269-
1 p.
 artikel
631 Improved results in pediatric oncology: More survivors, better survival, still much to do Lemerle, Jean
 1997
 33 S8 p. S132-
1 p.
 artikel
632 Improved survival using fractionated stereotactic radiosurgery (FSR) and concurrent taxol (T) for recurrent glioblastoma multiforme (RGM) Lederman, G.
 1997
 33 S8 p. S202-
1 p.
 artikel
633 Improvement in quality of pain relief for patients by academic detailing programme for Macmillan nurses Sandler, K.
 1997
 33 S8 p. S309-
1 p.
 artikel
634 Improving nurses' pain assessments: A nursing pain intervention study de Rond, M.E.J.
 1997
 33 S8 p. S298-
1 p.
 artikel
635 Improving tumour targeting and decreasing normal tissue uptake by optimizing stoichiometry of a two-step biotinylated monoclonal antibody (Mab)/streptavldin (Strv) based targeting strategy: Studies in a nude mouse xenograft model Maraveyas, A.
 1997
 33 S8 p. S87-
1 p.
 artikel
636 Incidence and sonographic features of hepatosplenic candidiaisis in patients with febrile neutropenia Karthaus, M.
 1997
 33 S8 p. S54-
1 p.
 artikel
637 Incidence of delayed infections after high-dose chemotherapy with peripheral blood stem cell support Yubero, A.
 1997
 33 S8 p. S94-
1 p.
 artikel
638 Incidence of malnutrition in head and neck cancer patients on commencing radiotherapy treatment at a regional oncology united in the United Kingdom Lees, J.
 1997
 33 S8 p. S323-
1 p.
 artikel
639 Increased serum deoxycholic acid levels in acromegalic patients with colorectal neoplasia Jenkins, P.J.
 1997
 33 S8 p. S171-S172
2 p.
 artikel
640 Increased serum levels of soluble receptor for tumour necrosis factor p-55 in melanoma patient Štabuc, B.
 1997
 33 S8 p. S259-
1 p.
 artikel
641 Increased serum α-L-fuccsidase activity in colorectal cancer patients Ayude, D.
 1997
 33 S8 p. S172-
1 p.
 artikel
642 Increase of HLA-DR+ T cell and decrease of CD8+ CD28+ putative cytotoxic cell with ‘naive’ phenotype (CD62Lhi) in cancer patient with dissemination Büssing, A.
 1997
 33 S8 p. S51-
1 p.
 artikel
643 Independent radiological review of a phase III study of topotecan versus paclitaxel as second-line therapy in advanced epithelial ovarian cancer Gwyther, S.J.
 1997
 33 S8 p. S119-S120
2 p.
 artikel
644 Individualized vaginal moulds using 192-lridium and CT evaluation in gynecological (Gyn) tumors Henríquez, I.
 1997
 33 S8 p. S108-S109
2 p.
 artikel
645 Individually modified involved field technique of the German/Austrian Pediatric Hodgkin Study (HD90): A way to reduce treatment volume without increase of relaps Dieckmann, K.
 1997
 33 S8 p. S125-
1 p.
 artikel
646 Individual nursing approach for patients with an I.A. hepatic access port Lokajner, G.
 1997
 33 S8 p. S331-
1 p.
 artikel
647 Induced radioresistance: Possible mechanisms and impact in the clinic Joiner, M.C.
 1997
 33 S8 p. S70-S71
2 p.
 artikel
648 Induction of AG-specific T cells by allogenic mamma carcinoma cells transfected with CD80 Meyer, G.C.
 1997
 33 S8 p. S85-
1 p.
 artikel
649 Induction preoperative chemotherapy with high-dose epirubicin in locally advanced breast cancer (LASC) Silestro, P.
 1997
 33 S8 p. S160-
1 p.
 artikel
650 Infection control in the neutropenic patient Bussy, Catherine
 1997
 33 S8 p. S326-
1 p.
 artikel
651 Infections at a hematology ward in a university hospital — Cost and preventive nursing Berg, Inger
 1997
 33 S8 p. S300-S301
2 p.
 artikel
652 Influence of allelism at GSTM1, GSTM3 and GSTP1 gene loci and enzyme expression on site-specific susceptibility to head and neck cancer Matthias, C.
 1997
 33 S8 p. S183-
1 p.
 artikel
653 Influence of ecologic factors on cancer incidence rates in some regions of Kyrgyzstan Kamarli, Z.
 1997
 33 S8 p. S130-
1 p.
 artikel
654 Influence of fractionation on the response of pulmonary micrometastases of the R1H-tumour to fractionated irradiation Raabe, Annette
 1997
 33 S8 p. S24-
1 p.
 artikel
655 Influence of long-term storage of freshly explanted tumor cells on in vitro soft agar cloning Peter, A.
 1997
 33 S8 p. S182-
1 p.
 artikel
656 Influence of low dose sullndac on p53 proteins, on BCL-2 protein and on TGFα in rectal mucosa biopsies of cancer prone patients (FAP) in a chemopreventive trial Winde, G.
 1997
 33 S8 p. S161-
1 p.
 artikel
657 Influence of melatonin on mutagenicity and anti-tumor effect of cyclophosphamide and nitrosomethylurea in mice Musatov, S.A.
 1997
 33 S8 p. S181-
1 p.
 artikel
658 Influence of specific glycanstrutures on the epidermal growth factor receptor (EGF-R) on cell growth Bergler, W.
 1997
 33 S8 p. S191-
1 p.
 artikel
659 Informational support for relative Eriksson, E.
 1997
 33 S8 p. S311-
1 p.
 artikel
660 Informed consent & cancer clinical trial Michael, Baum
 1997
 33 S8 p. S222-S223
2 p.
 artikel
661 Informed consent in cancer clinical trials and nurses role: An intervention study Ambaum, E.W.C.
 1997
 33 S8 p. S309-
1 p.
 artikel
662 Infusional 5-fluorouracil with and without calcium-folinat as second line therapy in advanced colorectal cancer — A retrospective cohort study of different protracted infusion regimens Gutzler, F.
 1997
 33 S8 p. S167-
1 p.
 artikel
663 Inhibited expression of fibronectin in laryngeal squamous cell carcinoma cell lines Görögh, T.
 1997
 33 S8 p. S186-
1 p.
 artikel
664 Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third generation aromatase inhibitor vorozole de Jong, P.Chr.
 1997
 33 S8 p. S9-
1 p.
 artikel
665 Inhibition of cisplatin-induced apoptosis by dexamethasone in cervical and bronchial carcinoma cells Ridder, R.
 1997
 33 S8 p. S173-
1 p.
 artikel
666 Inhibition of spontaneous apoptotic cell death of B-chronlc lymphocytic leukemia (B-CLL) cells by interleukin-12 in vitro Duensing, S.
 1997
 33 S8 p. S265-S266
2 p.
 artikel
667 Inhibition of tumor growth by an an tibody against a cell subtrate adhesion molecule Giffels, P.
 1997
 33 S8 p. S12-
1 p.
 artikel
668 Inhibitory effect of anti-angiogenic agent TNP-470 on lung metastasis from colon cancer Oda, H.
 1997
 33 S8 p. S51-
1 p.
 artikel
669 Inhibitory effect of radiosensltizer AK-2123 on experimental hepatic metastases and CA2+ active transport Konovalova, N.P.
 1997
 33 S8 p. S181-
1 p.
 artikel
670 Initial clinical features in patients of various age with non-Hodgkin's lymphomas Robu, M.V.
 1997
 33 S8 p. S270-
1 p.
 artikel
671 Insulin-like growth factor binding protein-3 (IGFBP-3) proteolysis in patients with colorectal cancer: A possible early prognostic factor of metastatic progression Bacluchka, M.
 1997
 33 S8 p. S167-S168
2 p.
 artikel
672 Integration of the cancer experiences in everyday life — A patient perspective Kopp, Kirsten
 1997
 33 S8 p. S325-
1 p.
 artikel
673 Intense local therapy in resectable rectal cancer Calvo, Felipe A.
 1997
 33 S8 p. S287-
1 p.
 artikel
674 Intensified chemotherapy with carboplatin and VP-16+G-CSF after induction with cyclophosphamide, epirubicln and vincristine (CEV) in extensive small cell lung cancer (SCLC). A phase II trial Crinò, L.
 1997
 33 S8 p. S234-
1 p.
 artikel
675 Intensified salvage therapy for germ cell cancer using sequential cycles of high dose carboplatin/etoposlde/cyclo-phosphamlde (CEC) Harstrick, A.
 1997
 33 S8 p. S40-
1 p.
 artikel
676 Intensive radiochemotherapy (RCT) with amifostine (A) in head and neck (H&N) cancer Büantzel, J.
 1997
 33 S8 p. S17-S18
2 p.
 artikel
677 Interdisciplinar and multidimensional approach in neoplastic aged patients Abbadessa, A.
 1997
 33 S8 p. S59-
1 p.
 artikel
678 Interferon-gamma (IFN-g) and interleukln-2 (IL-2) is a feasible and effective out-patient regimen for edvanced renal cell cancer Steger, G.G.
 1997
 33 S8 p. S41-
1 p.
 artikel
679 Interim report of a phase i study of docetaxel (Taxotere®) in combination with vinorelbine in chemotherapy naive patients with metastatic or inoperable non small cell lung cancer (NSCLC) Le Chevalier, T.
 1997
 33 S8 p. S233-
1 p.
 artikel
680 Interim report on toxicity and compliance of the FOGT-1 and FOGT-2 trials for adjuvant postoperative therapy in colonand rectal cancer Link, K.H.
 1997
 33 S8 p. S243-S244
2 p.
 artikel
681 Interim results of a phase II study of docetaxel (Taxotere™) in unresectable non-small cell lung cancer (NSCLC) on 204 chemotherapy naive or pretreated patients Mattson, K.
 1997
 33 S8 p. S229-
1 p.
 artikel
682 Interim results of a sequential administration of docetaxel (TAXOTERE®) followed by cisplatin-vindesine in chemotherapy naive patients with locally advanced or metastatic non small cell lung cancer (NSCLC) Antoine, E.C.
 1997
 33 S8 p. S240-
1 p.
 artikel
683 Interleukin-2 (IL-2). Interferon-α (IFN-α), 5-fluorouracil (5-FU) and vinblastine (VBL) for metastatic renal cell carcinoma (MRCC): A clinical and immunological study Gez, E.
 1997
 33 S8 p. S89-
1 p.
 artikel
684 Interleukin 12 supports immune responses towards human breast and ovarian carcinomas following initial CD80 mediated T cell activation Gückel, B.
 1997
 33 S8 p. S84-
1 p.
 artikel
685 Intermediate-high dose sequential single agent chemotherapy combined with irradiation in advanced Hodgkin's disease (HD) Bonfante, V.
 1997
 33 S8 p. S264-
1 p.
 artikel
686 Intestinal obstruction in cancer patients Wobbes, Th.
 1997
 33 S8 p. S73-
1 p.
 artikel
687 In the light of nursing scientist Kirsten Kopp’s project about patient education, 3 nurses in department of hematology made a education program for cancer patients and their relative Spile, Marianne
 1997
 33 S8 p. S314-
1 p.
 artikel
688 Intraarterial chemotherapy and transcatheter embolization (TE) in treatment of advanced uterine carcinomas (UC) Stolyarova, I.
 1997
 33 S8 p. S210-
1 p.
 artikel
689 Intraarterial chemotherapy (IACH) in patients with advanced primary central nervous system malignancies (APCNM) Pawelczak, A.
 1997
 33 S8 p. S203-
1 p.
 artikel
690 Intraartherial polychemotherapy and intraabdominal therapy with immobilazed chemodrugs in radical treatment of patients with III–IV stage of gastric cancer Valetsky, V.L.
 1997
 33 S8 p. S281-S282
2 p.
 artikel
691 Intraoperative HDR brachytherapy of Ewing's sarcoma Schuck, A.
 1997
 33 S8 p. S103-
1 p.
 artikel
692 Intraoperative (IORT)and external beam radiotherapy (EBRT) for extremity sarcomas Eble, M.J.
 1997
 33 S8 p. S112-
1 p.
 artikel
693 Intraoperative lymphatic mapping and identification of the sentinel node in breast cancer Flett, M.M.
 1997
 33 S8 p. S82-
1 p.
 artikel
694 Intraoperative radiotherapy (IORT) for recurrent rectal carcinoma Treiber, M.
 1997
 33 S8 p. S164-
1 p.
 artikel
695 Intraoperative radiotherapy (IORT) in soft tissue sarcoma Kretzler, A.
 1997
 33 S8 p. S113-
1 p.
 artikel
696 Intraoperative radiotherapy (IORT) of malignant brain tumors Prott, F.J.
 1997
 33 S8 p. S200-
1 p.
 artikel
697 Intraperitoneal 5-flurorouracil treatment in patients with non resectable pancreatic carcinoma Öman, M.
 1997
 33 S8 p. S282-S283
2 p.
 artikel
698 Intraperitoneal (IP) interferon A2b (INF) consolidation in cCR ovarian cancer (OC) patients following carboplatln chemotherapy (CT) Kosmidis, P.
 1997
 33 S8 p. S88-S89
2 p.
 artikel
699 Intratumor (IT) gene transfer with recombinant adenovlral (rAd) vectors in lung cancer (LC) patients (PTS): The institut Gustave Roussy (IGR) experience Tursz, T.
 1997
 33 S8 p. S136-
1 p.
 artikel
700 Intratumoural collagen/chemotherapy: Novel therapeutic strategy for accessible tumours Diffley, J.
 1997
 33 S8 p. S329-
1 p.
 artikel
701 Intravenou (i.v.) itasetron hydrochloride (DAU 6215Cl): An effective alternative to ondansetron (OND) Mignot, L.
 1997
 33 S8 p. S53-S54
2 p.
 artikel
702 Intravesical BEG-instillation therapy for superficial bladder cancer: A standard beneficial treatment beyond the understanding of its mode of action? Böhle, A.
 1997
 33 S8 p. S30-
1 p.
 artikel
703 Intravital lectin perfusion of tumours: Visualisation of efficiently and inefficiently perfused microvessels Debbage, P.L.
 1997
 33 S8 p. S24-
1 p.
 artikel
704 Introduction to tumour immunology and cancer vaccines Dalgeish, A.G.
 1997
 33 S8 p. S226-
1 p.
 artikel
705 Inverse relationship between apoptotic fraction and volume weighted mean nuclear volume in childhood Burkitts versus diffuse B/T large cell lymphoma Ball, L.M.
 1997
 33 S8 p. S269-S270
2 p.
 artikel
706 In vitro efficacy of transferrin conjugates of chlorambucil Beyer, U.
 1997
 33 S8 p. S183-
1 p.
 artikel
707 In vitro intraction of radiation and paclitaxel compared to the solvent cremophor EL/ethanol Plasswilm, L.
 1997
 33 S8 p. S24-
1 p.
 artikel
708 In-vitro radiosensitivity of lymphocytes and clinical radiation reaction Dunst, Jürgen
 1997
 33 S8 p. S100-
1 p.
 artikel
709 In vivo activity of a methotrexat-albumin-conjugate (MTX-HSA) in human tumor xenografts Fiebig, H.H.
 1997
 33 S8 p. S174-
1 p.
 artikel
710 In vivo evaluation of the lrinotecan-oxaliplatin comblnation Bissery, M.C.
 1997
 33 S8 p. S177-
1 p.
 artikel
711 In vivo resistance of murine leukemia P388 towards piatinum complexes Goncharova, S.
 1997
 33 S8 p. S181-
1 p.
 artikel
712 In vivo scintigraphic imaging of somatostatin receptors in sarcomas — Possible applications Giannakenas, C.
 1997
 33 S8 p. S116-
1 p.
 artikel
713 Involvement of Rho proteins in regulation of transformation and apoptosls Esteve, P.
 1997
 33 S8 p. S45-
1 p.
 artikel
714 Iridium-192 brachytherapy (BT) in head & neck cancer (H&NSCC) Grabenbauer, G.G.
 1997
 33 S8 p. S188-
1 p.
 artikel
715 Is acute mucositis dose limiting for altered fractionated radiotherapy? Maciejewski, B.
 1997
 33 S8 p. S97-
1 p.
 artikel
716 Is Chatelut formula applicable in obese patients for predicting carboplatin clearance? Bénézet, S.
 1997
 33 S8 p. S248-
1 p.
 artikel
717 Is cisplatin-taxol (PT) the standard treatment in advanced ovarian cancer. The NOCOVA Bertelsen, K.
 1997
 33 S8 p. S138-
1 p.
 artikel
718 Is dosimetry by planning CT the optimal method for external beam irradiation of the breast? De Pooter, Ch.
 1997
 33 S8 p. S108-
1 p.
 artikel
719 Is gamma linolenic acid potentially an effective intravesical agent for superficial bladder cancer? In vitro cytotoxicity and in vivo tolerance studies Solomon, L.Z.
 1997
 33 S8 p. S251-S252
2 p.
 artikel
720 Is micrometastasis the target of preference for monoclonal antibody therapy? Schlimok, G.
 1997
 33 S8 p. S69-
1 p.
 artikel
721 Isolated local recurrence in carcinoma of the vulva: Prognosis and implications for treatment Faul, C.
 1997
 33 S8 p. S205-
1 p.
 artikel
722 Is there a future for clinical use of bispecific monoclonal antibodies? Wamaar, S.O.
 1997
 33 S8 p. S69-
1 p.
 artikel
723 Is there any use in accelerated and hyperfractionated radiotherapy in locally advanced head and neck cancer? Monney, M.
 1997
 33 S8 p. S185-
1 p.
 artikel
724 Is there a role of 3-dimensional conformal boost for the treatment of medulloblastoma? Tiefenbacher, U.
 1997
 33 S8 p. S202-S203
2 p.
 artikel
725 Is there a safe dose for spinal cord after hyperfractlonated and conventional radiotherapy? Niewald, M.
 1997
 33 S8 p. S97-
1 p.
 artikel
726 IT — Actions to improve the quality of chemotherapy for patients receiving cancer treatment Nelausen, Knud Mejer
 1997
 33 S8 p. S55-
1 p.
 artikel
727 Itasetron hydrochloride (DAU 6215Cl): A pharmacoklnetlcally unique 5-HT3 antagonist Schilling, C.
 1997
 33 S8 p. S55-
1 p.
 artikel
728 Kinetics of MTX-albumin conjugates in rats Wunder, A.
 1997
 33 S8 p. S177-
1 p.
 artikel
729 Knowledge and beliefs about cancer prevention in a Northeast Italian population Robbiati, S.F.
 1997
 33 S8 p. S129-
1 p.
 artikel
730 Koilocytotic lesions and cervical cancer in Moldova: An morphoepidemiological study Chemy, A.P.
 1997
 33 S8 p. S211-
1 p.
 artikel
731 Laparoscopic surgery for colorectal cancer — Is it safe? Guillou, P.J.
 1997
 33 S8 p. S288-
1 p.
 artikel
732 Laryngeal cancer T3N0M0: Variations in organ-preservation treatment Alferov, V.
 1997
 33 S8 p. S190-
1 p.
 artikel
733 Larynx conservation in a randomized trial of hyperfractionated (HFRT)versus conventional once daily radiation (CRT): A subgroup analysis Cummings, B.J.
 1997
 33 S8 p. S254-
1 p.
 artikel
734 Late cardiac effects after adjuvant radiotherapy following mastectomy in early breast cancer Gustavsson, A.
 1997
 33 S8 p. S104-
1 p.
 artikel
735 Late deaths of long term survivors after childhood cancer Lemarie, Jean
 1997
 33 S8 p. S141-
1 p.
 artikel
736 "Learning to live with cancer": Also an italian experience Mazza, R.
 1997
 33 S8 p. S313-
1 p.
 artikel
737 Lessons from prospective multicenter study on seminomas Weißbach, L.
 1997
 33 S8 p. S37-
1 p.
 artikel
738 Letrozole (FEMARA®), a new potent, selective aromatase inhibitor (AI): Superior to another AI, aminoglutethimlde (AG), in postmenopausal women with advanced breast cancer (ABC), after relapse or progression on previous anti-estrogen therapy Possinger, K.
 1997
 33 S8 p. S145-
1 p.
 artikel
739 Liaison® Ferritin — An automated chemliuminescent immunoassay for the determination of Ferritin Mack, M.
 1997
 33 S8 p. S51-
1 p.
 artikel
740 Liaison® free PSA, development of an automated chemiluminescence immunoassay for the determination of free prostate specific antigen (fPSA) Mack, M.
 1997
 33 S8 p. S49-
1 p.
 artikel
741 Liaison® hCG — An automated chemiluminescent immunoassay for the determination of human chorionic gonadotropin Mack, M.
 1997
 33 S8 p. S52-
1 p.
 artikel
742 Liposomal daunorubicin in children with brain tumors Lippens, R.
 1997
 33 S8 p. S203-
1 p.
 artikel
743 Liposomal daunorubicln in combination with paclitaxel in metastatic breast cancer: A dose finding study Schuize, K.
 1997
 33 S8 p. S158-
1 p.
 artikel
744 Liver resection and liver transplantation for primary hepatocellular carcinoma Reck, Th.
 1997
 33 S8 p. S278-
1 p.
 artikel
745 Liver resection for hepatic malignancles: Current approaches and future perspectives Bismuth, Henri
 1997
 33 S8 p. S215-
1 p.
 artikel
746 Local control and overall treatment time in the radiotherapy of laryngeal cancer Cernea, V.
 1997
 33 S8 p. S188-
1 p.
 artikel
747 Local control in breast conservation George, W.D.
 1997
 33 S8 p. S293-S294
2 p.
 artikel
748 Local hyperthermia in the treatment of soft-tissue sarcomas Ivanov, S.M.
 1997
 33 S8 p. S114-
1 p.
 artikel
749 Local intratumoral immunotherapy of prostate cancer with interleukln-2 reduces tumor growth significantly Hautmann, S.
 1997
 33 S8 p. S33-
1 p.
 artikel
750 Localised soft tissue sarcomas. Treatment results and prognostic factors Cemea, Dana
 1997
 33 S8 p. S115-
1 p.
 artikel
751 Locally advanced and metastatic thyroid cancer — 15-year results of adjuvant or palliative external beam radiotherapy Seegenschmiedt, M.H.
 1997
 33 S8 p. S101-
1 p.
 artikel
752 Long follow-up of gastric lymphoma Jorge, M.
 1997
 33 S8 p. S277-
1 p.
 artikel
753 Long-term assessment of dysplasia, DNA ploidy, proliferation and p53 alteration in ulcerative colitis Habermann, J.
 1997
 33 S8 p. S14-
1 p.
 artikel
754 Long term breast cancer treatment with tamoxifen and second primary tumors Stathopoulos, G.P.
 1997
 33 S8 p. S150-S151
2 p.
 artikel
755 Long-term effects of testicular cancer treatment on sexual functioning Hartmann, J.T.
 1997
 33 S8 p. S38-
1 p.
 artikel
756 Long-term physical and psychological sequelae in patients treated with high-dose chemotherapy with peripheral stem cell rescue Caial, R.
 1997
 33 S8 p. S61-
1 p.
 artikel
757 Long-term prognostic impact of PAI-1 in primary breast cancer confirmed by six-year median follow-up Harbeck, N.
 1997
 33 S8 p. S194-
1 p.
 artikel
758 Long-term results of chemotherapy in advanced thyroid carcinoma Bueso, P.
 1997
 33 S8 p. S192-
1 p.
 artikel
759 Long-term survival after complete response to chemotherapy in small cell lung cancer depends on cytokine secretion capacity at diagnosis Fischer, J.R.
 1997
 33 S8 p. S227-S228
2 p.
 artikel
760 Long-term survival and late toxicities after high-dose chemotherapy in patients suffering from germ cell cancer Rick, O.
 1997
 33 S8 p. S37-S38
2 p.
 artikel
761 Long-term survival in axillary node-positive breast cancer treated with locoregional therapy alone Joensuu, H.
 1997
 33 S8 p. S81-
1 p.
 artikel
762 Long term survivors from a European-Canadian trial of paclitaxel in platinum-pretreated ovarian cancer (OVCA) Eisenhauer, E.
 1997
 33 S8 p. S119-
1 p.
 artikel
763 Long-term therapeutic efficacy and toxicity of recombinant interferon-alpha 2a in polycythemia vera Foa, P.
 1997
 33 S8 p. S88-
1 p.
 artikel
764 Long-term weekly treatment of advanced colorectal cancer (CRC) with fluorouracil (5-FU) and leucovorin (LV): 5 year-results of a multicentric phase II trial of 5-FU pharmacokinetic monitoring in 152 patients Lamezec, B.
 1997
 33 S8 p. S163-
1 p.
 artikel
765 Loss of E-cadherin expression has a prognostic value for bladder carcinoma patients Torregrosa, A.
 1997
 33 S8 p. S34-
1 p.
 artikel
766 Low dose hyperfractionated craniospinal radiation therapy for childhood cerebellar medulloblastoma: Early results of a phase I–II study Ricard, U.
 1997
 33 S8 p. S201-S202
2 p.
 artikel
767 Low dose irradiation for macular degeneration Sagerman, R.H.
 1997
 33 S8 p. S101-
1 p.
 artikel
768 Low-dose tamoxifen trial in healthy women Bonanni, B.
 1997
 33 S8 p. S10-S11
2 p.
 artikel
769 Low incidence of myelodysplasia (MDS) or acute leukemia (AML) after autologous blood or marrow transplant without total body radiation (TBI) for lymphoma Crump, M.
 1997
 33 S8 p. S93-
1 p.
 artikel
770 Low toxicity (TOX) of a prolonged infusion of gemcltablne (GEM) Späth-Schwalbe, E.
 1997
 33 S8 p. S253-
1 p.
 artikel
771 Lung cancer after therapy of hodgkin disease: Influence of treatment and smoking Tate, D.
 1997
 33 S8 p. S17-
1 p.
 artikel
772 Lung cancer needs assessment Krishnasamy, Meiner
 1997
 33 S8 p. S332-
1 p.
 artikel
773 Lung cancer — Prognosis and classification Drings, P.
 1997
 33 S8 p. S227-
1 p.
 artikel
774 Lung cancer prognosis: The role of the metastatic pattern Buccheri, G.
 1997
 33 S8 p. S234-
1 p.
 artikel
775 Lymphatic drug targeting with liposomal mitoxantrone for breast cancer — Results of a pilot study Nagel, D.
 1997
 33 S8 p. S176-
1 p.
 artikel
776 Lymphatic mapping and sentinel node biopsy Nieweg, O.E.
 1997
 33 S8 p. S141-
1 p.
 artikel
777 Lymphocyte abnormalities during post-chemotherapy myelosuppression and bone marrow regeneration in patients with solid tumors Georgoulias, V.
 1997
 33 S8 p. S96-
1 p.
 artikel
778 Lymphoedema — Is Current Management Effective? — An Audit Green, Gene
 1997
 33 S8 p. S323-S324
2 p.
 artikel
779 Magnetic resonance imaging (MRI) of pulmonary lesions with single shot fast and ultra-fast gradient echo imaging Bischoff, H.G.
 1997
 33 S8 p. S229-
1 p.
 artikel
780 Magnetic resonance imaging of bone marrow versus biopsy in malignant lymphoma Özgüroğlu, M.
 1997
 33 S8 p. S270-
1 p.
 artikel
781 Magnetotherapy for treatment of radiodermatitis Frezza, P.
 1997
 33 S8 p. S21-
1 p.
 artikel
782 Malignant mesothelioma: In vitro responses to new chemotherapeutic agents, and correlation to GSTM1 and NAT2 gene polymorphism Mattson, K.
 1997
 33 S8 p. S175-
1 p.
 artikel
783 Malignant pleural mesothelioma (MM): Outcome following radiotherapy in 300 patients de Graaf-Strukowska, L.
 1997
 33 S8 p. S98-S99
2 p.
 artikel
784 Malignant tumors in patients with HIV infection Tirelli, U.
 1997
 33 S8 p. S6-
1 p.
 artikel
785 Mammary carcinoma: Prognostic value of histology, proliferative indicator receptor statu and expression of oncogen product in node-free patient Niezabitowski, A.
 1997
 33 S8 p. S198-
1 p.
 artikel
786 Management of early stage Hodgkin's disease (HD) in 1997 Cosset, J.M.
 1997
 33 S8 p. S220-
1 p.
 artikel
787 Management of febrile neutropenia in 272 episodes in solid tumor patients with once daily administration of ceftriaxone Karthaus, M.
 1997
 33 S8 p. S54-
1 p.
 artikel
788 Management of stage I–II primary gastric non MALT-type lymphoma Ferreri, A.J.M.
 1997
 33 S8 p. S261-
1 p.
 artikel
789 Mapping drug distribution patterns in solid tumors: Toward conformal chemotherapy for local tumor control Kanekal, S.
 1997
 33 S8 p. S179-S180
2 p.
 artikel
790 Marine organisms — Are they a worthwhile source? Kaye, S.B.
 1997
 33 S8 p. S218-
1 p.
 artikel
791 Matrix metalloproteinase inhibitors Verweij, J.
 1997
 33 S8 p. S218-
1 p.
 artikel
792 Mature results from the 'Tomudex' (raltitrexed) comparative study in advanced colorectal cancer (ACC) Kerr, D.
 1997
 33 S8 p. S243-
1 p.
 artikel
793 Measurement of radiosensitivity in cervical tumours on the basis of the comet assay Biesaga, B.
 1997
 33 S8 p. S27-
1 p.
 artikel
794 Measurement of workload in clinical trial Gall, Helen
 1997
 33 S8 p. S316-S317
2 p.
 artikel
795 Mechanisms of vaccination with cytoklne gene-transduced cell Foml, C.
 1997
 33 S8 p. S135-
1 p.
 artikel
796 Metastases of unknown primary tumor (UPT) Hoekstra, H.J.
 1997
 33 S8 p. S225-
1 p.
 artikel
797 Metastatic ocular melanoma — Experiences with chemolmmuno-/polychemotherapy Uhl, K.
 1997
 33 S8 p. S260-
1 p.
 artikel
798 Metastatic osteogenic sarcoma (OS) at diagnosis. Study of 73 cases from the french society of pediatric oncology (SFOP) between 1980 and 1990 Pacquement, H.
 1997
 33 S8 p. S124-
1 p.
 artikel
799 Metphosphane — A potent anticancer agent Stamulytė, Z
 1997
 33 S8 p. S182-
1 p.
 artikel
800 MIB-1 and ploidy in head & neck cancer (SCC H&N) Mohr, J.
 1997
 33 S8 p. S186-S187
2 p.
 artikel
801 Microsatellite instability in gastric cancer Wirtz, H.-Ch.
 1997
 33 S8 p. S275-
1 p.
 artikel
802 Minimal invasive surgery in oncology Siewert, J.R.
 1997
 33 S8 p. S214-
1 p.
 artikel
803 Mirror, mirror on the wall: Evaluating the process of nursing care, the nurses point of view Lafleur, J.
 1997
 33 S8 p. S300-
1 p.
 artikel
804 Mitoxantrone (N) vs. 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as first line therapy in high-risk metastatic breast cancer von minckwitz, G.
 1997
 33 S8 p. S145-S146
2 p.
 artikel
805 Models of environmental effects on intestinal tumour development Wasan, Harpreet S.
 1997
 33 S8 p. S217-
1 p.
 artikel
806 Modifying the Gill-Thomas-Cosman (GTC) head frame to expand the range of fractionated stereotactic radiosurgery (FSR) Lederman, G.
 1997
 33 S8 p. S203-
1 p.
 artikel
807 Modulating endogenous retinoic acid (En-RA) levels with RAMBAs may produce fewer slde-effects (SEs) than exogenous RA (Ex-RA) Boccardo, F.
 1997
 33 S8 p. S30-
1 p.
 artikel
808 Modulation of tamoxifen adjuvant hormonal treatment according to first generation prognostic factors in 702 pT1-2/pN0-1(≤3)/M0 breast cancer, treated by surgery and external irradiation Bolla, M.
 1997
 33 S8 p. S84-
1 p.
 artikel
809 Molecular and biologic markers of DCIS, ADH and IDC Ménard, Sylvie
 1997
 33 S8 p. S67-
1 p.
 artikel
810 Molecular biology of pancreatic cancer and implications for gene therapy Lemoine, N.R.
 1997
 33 S8 p. S136-
1 p.
 artikel
811 Molecular evolution of the esophagitis metaplaslaadenocarclnoma sequence (EMAS): Paradigms and paradoxs for cancer biology Jankowski, J.
 1997
 33 S8 p. S292-
1 p.
 artikel
812 Molecular intervention in small cell lung cancer Stahel, R.A.
 1997
 33 S8 p. S286-
1 p.
 artikel
813 Molecular radiation biology at the clinical interface McKenna, G.W.
 1997
 33 S8 p. S70-
1 p.
 artikel
814 Monitoring treatment of bone metastases Curley, E.
 1997
 33 S8 p. S148-S149
2 p.
 artikel
815 Monoclonal antibodies in combination with growth factors and chemotherapeutics Mellstedt, H.
 1997
 33 S8 p. S69-
1 p.
 artikel
816 Morbidity of a combined modality therapy of intra-arterial doxorubicin, neoadjuvant radiotherapy and surgery for locally advanced high grade soft tissue sarcomas (STS) of the extremities Nijhuis, P.
 1997
 33 S8 p. S113-
1 p.
 artikel
817 Morbidity of external beam irradiation in patients with locally advanced prostate cancer: Analysis of our experience Pęczkowski, P.
 1997
 33 S8 p. S33-
1 p.
 artikel
818 MRI and endoluminal ultrasound result in different staging in 5 out of 17 patients with anal cancer Wiegel, T.
 1997
 33 S8 p. S170-S171
2 p.
 artikel
819 99m-Tc-sestamibi extrusion rate correlates with resistance to cytotoxic treatment and distant metastasis in non-small cell lung cancer Koukouraki, S.
 1997
 33 S8 p. S230-
1 p.
 artikel
820 99mTc-Tetrofosmin in breast cancer Kubista, P.
 1997
 33 S8 p. S159-
1 p.
 artikel
821 Mucositis prevention (PM), nursing protocol Salazar, Joyce
 1997
 33 S8 p. S301-
1 p.
 artikel
822 Multicenter comparison of intravenous granlsetron (G) alone or In combination with dexamethasone (GD) in the prevention of nausea and vomiting associated with moderate and highly emetogenic chemotherapy (CH) — The Hungarian experience Géozi, L.
 1997
 33 S8 p. S56-
1 p.
 artikel
823 Multicultural cancer nursing care Boyle, D.A.
 1997
 33 S8 p. S331-
1 p.
 artikel
824 Multidrug resistance modifiers: Molecular modelling using comparative molecular field analysis Wiese, M.
 1997
 33 S8 p. S178-
1 p.
 artikel
825 Multi modal cancer care — The role of the surgeon O’Higgins, Niall
 1997
 33 S8 p. S143-
1 p.
 artikel
826 Mutant ras peptide vaccines Gaudemack, Gustav
 1997
 33 S8 p. S289-
1 p.
 artikel
827 Mutations in the BRCA1 gene in it alian breast and ovarian cancer patients Ottini, L.
 1997
 33 S8 p. S9-
1 p.
 artikel
828 MVP versus (vs) MVP plus chemo-radiotherapy in stage III NSCLC: Preliminary results Rebischung, J.-L.
 1997
 33 S8 p. S235-
1 p.
 artikel
829 Myeloablative therapy, stem cell rescue and gene transfer in advanced ewing tumors (AET) Burdach, St.
 1997
 33 S8 p. S125-
1 p.
 artikel
830 Nasopharyngeal carcinomas of childhood Serin, M.
 1997
 33 S8 p. S126-
1 p.
 artikel
831 Nasopharyngeal carcinoma: Two different treatments (radiotherapy vs neoadyuvant chemotherapy and radiotherapy) Rodríguez, A.
 1997
 33 S8 p. S191-
1 p.
 artikel
832 Navelbine (NVB) and Doxorubicin (DX) both at 25 mg/m2, on days 1 & 8 for the management of advanced breast cancer (ABC) Anelli, A.
 1997
 33 S8 p. S151-
1 p.
 artikel
833 Navelbine (NVB), and fractionated dose doxorubicin (DX) improves first line advanced breast cancer (ABC) chemotherapy. An overview of 3 phase II trials Carmichael, J.
 1997
 33 S8 p. S146-
1 p.
 artikel
834 Navelbine (NVB) plus mitomycin (MMC) or mitoxantrone (MTZ) as salvage regimen in metastatic breast cancer (MBC): A randomized trial Lozano, M.
 1997
 33 S8 p. S154-
1 p.
 artikel
835 Navelblne (NVB) and fractionated doses of clsplatin (COOP) for the treatment of advanced non-small cell lung cancer (NSCLC) Altino, J.
 1997
 33 S8 p. S241-
1 p.
 artikel
836 Navelblne (NVB), oral etoposide (VP16), in advanced non-small cell lung cancer (NSCLC) López, J.O.
 1997
 33 S8 p. S240-
1 p.
 artikel
837 Neoadjuvant chemotherapy before radiotherapy of advanced head and neck cancer in Ukraine Katchmar, T.B.
 1997
 33 S8 p. S190-
1 p.
 artikel
838 Neoadjuvant chemotherapy followed by radical hysterectomy or radiotherapy for FIGO III and IV cervical cancer: A pllot study Schnohr, Sabine I.
 1997
 33 S8 p. S211-
1 p.
 artikel
839 Neo-adjuvant chemotherapy in adult soft tissue sarcoma. EORTC Protocol 62847 Gortzak, E.
 1997
 33 S8 p. S138-S139
2 p.
 artikel
840 Neoadjuvant chemotherapy in bladder cancer: Is cistectomy mandatory in case of complete response? Baiocchi, C.
 1997
 33 S8 p. S36-
1 p.
 artikel
841 Neoadjuvant chemotherapy with navelbine (NVB) plus clsplatin (C) in stage IIIB in non-small cell lung cancer (NSCLC): A phase II trial Cigolari, S.
 1997
 33 S8 p. S241-
1 p.
 artikel
842 Neoadjuvant cisplatin- vindeslne/vinorelbine based combination chemotherapy (CT) for stage III non-small cell lung cancer (NSCLC) Ciuleanu, T.E.
 1997
 33 S8 p. S233-
1 p.
 artikel
843 Neoadjuvant long-term continuous intra-arterial chemotherapy of soft tissue sarcomas Bokhlan, B.Y.
 1997
 33 S8 p. S113-S114
2 p.
 artikel
844 Neoadyuvant chemotherapy with cisplatin (CDDP)plus 5-FU vs. cisplatin plus UFT in locally-advanced squamous head and neck cancer García Carbonero, I.
 1997
 33 S8 p. S189-S190
2 p.
 artikel
845 Neoplastic patients and awareness of the diagnosis Destefanis, M.
 1997
 33 S8 p. S61-
1 p.
 artikel
846 Never say never to self-care. Stoma patients and family education Geva, T.
 1997
 33 S8 p. S310-
1 p.
 artikel
847 New approach to staging the axilla by endoscopic axillary lymphadenectomy (EAL) in early breast cancer Suzanne, F.
 1997
 33 S8 p. S135-
1 p.
 artikel
848 New dimethyltin (IV) compounds and their complexes with nitrogen containing ligands of antitumour activity Rashan, Luay J.
 1997
 33 S8 p. S182-
1 p.
 artikel
849 New drug developments: Implications for nursing practice Knowles, Gillian
 1997
 33 S8 p. S327-
1 p.
 artikel
850 New drugs and new strategies for women with breast cancer Piccart, M.J.
 1997
 33 S8 p. S216-S217
2 p.
 artikel
851 New drugs and their possible impact on patient outcome Bleiberg, H.
 1997
 33 S8 p. S287-
1 p.
 artikel
852 New radiotherapy fractionation schemes in head and neck cancers. The EORTC trials: A benchmark Horiot, J.C.
 1997
 33 S8 p. S133-
1 p.
 artikel
853 New treatment modalities and their consequences for nursing staff Schanz, W.
 1997
 33 S8 p. S338-
1 p.
 artikel
854 Non Hodgkin lymphoma (NHL) & hepatitis C in Egypt: Prevalence, clinical characteristics & response to therapy in a randomized controlled trial Hashem, T.
 1997
 33 S8 p. S268-S269
2 p.
 artikel
855 Non-small cell lung cancer: How exsive should surgery be? Schirren, J.
 1997
 33 S8 p. S287-
1 p.
 artikel
856 Non-surgical treatment in primarily resectable T3T4 larynx and hypopharynx SCC Lefebvre, J.L.
 1997
 33 S8 p. S290-
1 p.
 artikel
857 Nordic cancer union: Programs in communication a way to increase patients satisfaction Hagen, Steinar
 1997
 33 S8 p. S222-
1 p.
 artikel
858 Nosocomial invasive aspergillosis among neutropenic patients with acute hematological malignancies: Contribution of nursing intervention and patient education in effective prevention Sofer, A.
 1997
 33 S8 p. S310-S311
2 p.
 artikel
859 N-oxide derivatives of chlorambucil as agents for overcoming hypoxic cell radiation resistance Horsman, M.R.
 1997
 33 S8 p. S97-
1 p.
 artikel
860 Nuclear accumulation of wildtype p53 protein cannot be related to complex formation with mdm2 in human renal cell carcinoma cell lines Jaquet, K.
 1997
 33 S8 p. S41-
1 p.
 artikel
861 Nucleolar organizer regions (NORs), mitotin expression, and caseine kinase II (CKII) activity in melanocytic naevi and malignant melanoma Botev, I.
 1997
 33 S8 p. S259-
1 p.
 artikel
862 Number of CD34+cells infused and duration of aplasia after high-close chemotherapy Herráez, J.
 1997
 33 S8 p. S93-
1 p.
 artikel
863 Nurses experiences of caring for dying patients in an oncology setting Hodgkiss, Sharon
 1997
 33 S8 p. S308-
1 p.
 artikel
864 Nurse-supervision to the newly employed nurses, and to the nurses changing wards during reorganisation at Finsen Center, of the National University Hospital of Denmark Norberg, Birgit
 1997
 33 S8 p. S335-
1 p.
 artikel
865 Nursing and AIDS — Challenges for nurses Sanchis, C.
 1997
 33 S8 p. S319-
1 p.
 artikel
866 Nursing diagnoses — Benefit or burden for cancer nurses Redmond, K.
 1997
 33 S8 p. S319-
1 p.
 artikel
867 Nursing dialogues: Pancreas cancer, gemcitabine and clinical benefit response Barton Burke, M.
 1997
 33 S8 p. S303-
1 p.
 artikel
868 Nursing implications of the management of anaemia-related fatigue with epoetin alfa (Eprex®) Aalst, J.G.B. v.
 1997
 33 S8 p. S328-
1 p.
 artikel
869 Nursing protocol committees, one of three steps to improve quality Rasmussen, Annie
 1997
 33 S8 p. S316-
1 p.
 artikel
870 Nursing protocols within the clinical palliative care setting van der Meijden, B.
 1997
 33 S8 p. S304-
1 p.
 artikel
871 Nursing summaries of clinical trial Ambaum, E.W.C.
 1997
 33 S8 p. S316-
1 p.
 artikel
872 Nursing views on complications of subcutaneous venous access ports Verhoeven, D.
 1997
 33 S8 p. S330-
1 p.
 artikel
873 Oncogene activation as a prognostic marker in head and neck cancer Schuuring, E.
 1997
 33 S8 p. S289-
1 p.
 artikel
874 Oncology nursing — Approaching a new millennium Glaus, A.
 1997
 33 S8 p. S305-
1 p.
 artikel
875 On the molecular genetics of malignant melanoma Ringborg, U.
 1997
 33 S8 p. S291-
1 p.
 artikel
876 Optimal duration of neoadjuvant chemotherapy: 3 or 4 versus 6 cycles in 3 schemes for operable breast cancer Charrier, S.
 1997
 33 S8 p. S83-
1 p.
 artikel
877 Optimal results in breast conserving therapy: The interaction between the surgeon and radiation oncologist Bartelink, H.
 1997
 33 S8 p. S134-S135
2 p.
 artikel
878 Optimized detection of 5-S-cysteinyldopa (5-S-CD) in serum of melanoma patients: A new marker of metastatic Stockfleth, E.
 1997
 33 S8 p. S257-
1 p.
 artikel
879 Optimizing the efficacy of epirubicin as an intravesical chemotherapy agent. Can it be buffered to ph 8? Inman, L.
 1997
 33 S8 p. S248-
1 p.
 artikel
880 Oral etoposide in patients (pts) with Kaposi's sarcoma (KS) Aydiner, A.
 1997
 33 S8 p. S260-
1 p.
 artikel
881 Oral etoposide in patients with small cell lung cancer Topuz, E.
 1997
 33 S8 p. S237-
1 p.
 artikel
882 Oral etoposide plus clsplatin alternating with ifosfamide-eplrubicin-vincristine in small cell lung cancer (SCLC) Cruz, J.J.
 1997
 33 S8 p. S241-
1 p.
 artikel
883 Oral itasetron hydrochloride (DAU 6215Cl) versus ondansetron (OND): Comparable efficacy at a lower dose Salwender, H.
 1997
 33 S8 p. S53-
1 p.
 artikel
884 Oral squamous cell carcinoma (OSCC) — The role of to the tumor associated proteases uPA, PAI-1, cathepsin D, cathepsin B, cathepsin L and the receptor uPA-R Zeilhofe, H.-F.
 1997
 33 S8 p. S184-
1 p.
 artikel
885 Organ preservation and survival with surgical treatment for larynx carcinoma Eckel, H.E.
 1997
 33 S8 p. S254-
1 p.
 artikel
886 Orthotopic transplantation of intact human colorectal and pancreatic tumor tissue in nude mice Cui, J.H.
 1997
 33 S8 p. S170-
1 p.
 artikel
887 Orthotoplcally transplanted human synovial sarcoma xenografts in nude mice Cmalic, S.
 1997
 33 S8 p. S115-
1 p.
 artikel
888 Osteoblastic metastases: Metabolic and morphologic aspects Francini, G.
 1997
 33 S8 p. S35-
1 p.
 artikel
889 Our experience with classlclfatlon of nurse’s diagnoses in health care for patients in oncology (oncology patients) Milović, Lj.
 1997
 33 S8 p. S339-
1 p.
 artikel
890 Out experience in planning and training of professional staff for health care Nikolić, S.
 1997
 33 S8 p. S302-
1 p.
 artikel
891 Outome of advanced epithelial ovarian cancer in women under 40 years Pires de Miranda, M.
 1997
 33 S8 p. S118-
1 p.
 artikel
892 Ovarian cancer — Are we making progress? Bjorge, T.
 1997
 33 S8 p. S139-S140
2 p.
 artikel
893 Ovarian cancer: Progress in chemotherapy Neijt, J.P.
 1997
 33 S8 p. S140-
1 p.
 artikel
894 Overexpression of p53 and MDM2 proteins in soft tissue tumors. The correlation with p53 gene mutations and searching for prognostic factors Ryś, J.
 1997
 33 S8 p. S117-
1 p.
 artikel
895 Oxaliplatin (LOHP) and 5-fluorouracil (5-FU) synergism in advanced colorectal cancer patients (ACRC) Meyer, V.
 1997
 33 S8 p. S167-
1 p.
 artikel
896 Oxygen tension in metastatic lymph nodes and the changes during acute respiratoric hypoxia Strnad, V.
 1997
 33 S8 p. S26-
1 p.
 artikel
897 Paclitaxel-induced growth supression and morphological alterations in different types of human renal cell carcinoma Reinecke, P.
 1997
 33 S8 p. S42-
1 p.
 artikel
898 Paclitaxel (P) and cisplatin (C) as salvage treatment for nonseminomatous germ cell tumor (NSGCT) patients (pts) Tjulandin, S.
 1997
 33 S8 p. S40-
1 p.
 artikel
899 Paclitaxel (P) Taxol® plus epirubicln (E) as first-line therapy In patients (pts) with advanced breast cancer (ABC) a preliminary analysis Ventriglia, M.
 1997
 33 S8 p. S157-
1 p.
 artikel
900 Paclitaxel (PX) — Carboplatin (CBP) versus cyclophosphamide (CTX)-carboplatin supported by G-CSF as first line chemotherapy in figo III–IV ovarian carcinoma (O.C.) Polyzos, A.
 1997
 33 S8 p. S122-
1 p.
 artikel
901 Paclitaxel (T) plus 5-fluorouraciL (5-FU): A novel and very active regimen for advanced gastric cancer (AGC). A phase II trial Murad, A.M.
 1997
 33 S8 p. S277-S278
2 p.
 artikel
902 Paget’s disease of the breast treated with radiotherapy only Christiaens, M.R.
 1997
 33 S8 p. S81-
1 p.
 artikel
903 Pain assessment: A careful assessment of the intensity and multiple dimensions of a pain syndrome are the main steps towards adequate treatment Mohr, Wenche
 1997
 33 S8 p. S306-
1 p.
 artikel
904 Pain management in cancer patient at home: The role and view of patient and professional Duijnhouwer, E.
 1997
 33 S8 p. S52-
1 p.
 artikel
905 Pair: Palliative accelerated irradiation regimen for non-small-cell lung cancer: Final results of the pilot study Nestle, U.
 1997
 33 S8 p. S237-S238
2 p.
 artikel
906 Palliative approaches in oesophageal cancer Hennessy, T.P.J.
 1997
 33 S8 p. S292-
1 p.
 artikel
907 Palliative care in Europe Einhorn, J.
 1997
 33 S8 p. S73-
1 p.
 artikel
908 Palliative complex treatment of the patients with ovarian cancer by using of radiation component Vorobyova, L.
 1997
 33 S8 p. S124-
1 p.
 artikel
909 Palliative home care unit (PHCU). Project of care of terminally ill cancer patients in their homes Capra, S.
 1997
 33 S8 p. S304-
1 p.
 artikel
910 Palliative management of breast carcinoma skin metastases using 6% miltefoslne solution applied topically: Results of a compassionate use programme Cheverton, P.D.
 1997
 33 S8 p. S148-
1 p.
 artikel
911 Palliative treatment of accessible solid tumors with intratumoral cisplatin/epinephrlne injectable gel Burris III, H.
 1997
 33 S8 p. S54-
1 p.
 artikel
912 Pathological changes of the cervix ressembling malignant lymphoma Berisavac, M.
 1997
 33 S8 p. S213-
1 p.
 artikel
913 Pathways and time effect of radiation-induced apoptosis Verheij, M.
 1997
 33 S8 p. S70-
1 p.
 artikel
914 Patient attitudes towards video directed information — A multicentre study Deary, A.
 1997
 33 S8 p. S310-
1 p.
 artikel
915 Patient needs as analysed through national “helplines” Christensen, Lilly
 1997
 33 S8 p. S222-
1 p.
 artikel
916 Patients attitudes towards an individualized filofax information system Kaminski, E.
 1997
 33 S8 p. S313-
1 p.
 artikel
917 Patients' judgements on new epicutaneous breast forms Münstedt, K.
 1997
 33 S8 p. S60-
1 p.
 artikel
918 Patients' perceptions of bone marrow transplantation Thain, Colin
 1997
 33 S8 p. S299-
1 p.
 artikel
919 Patients preferences for and satisfaction to a breast care nurse specialist Shingler, G.
 1997
 33 S8 p. S312-
1 p.
 artikel
920 Patients preferences for involvement in treatment decisions in palliative cancer care Lutz, M.P.
 1997
 33 S8 p. S74-
1 p.
 artikel
921 Patients who die: Nurses also grieve Owen, J.
 1997
 33 S8 p. S308-
1 p.
 artikel
922 PCR based detection of melanoma cells: Molecular staging? Keilholz, U.
 1997
 33 S8 p. S45-
1 p.
 artikel
923 PCR-SSCP technique for the detection of mutation in the exons 5 and 6 of the p53 gene in breast cancer. Higher sensitivity than immunohistochemical technique Dueñas, A.
 1997
 33 S8 p. S10-
1 p.
 artikel
924 PDQ: A comprehensive cancer information database — The U.S. experience Haller, D.G.
 1997
 33 S8 p. S292-
1 p.
 artikel
925 Peptide loaded human autologous dendritic cells (DC's) as a potential anti-cancer vaccine Adams, M.
 1997
 33 S8 p. S86-
1 p.
 artikel
926 Peptide receptor radionuclide therapy (PRRT) with [IN-111-DTPA0]octreotide (In-111-0C) in rats bearing the pancreatic somatostatin receptor (SSR) positive tumor CA20948 van Eijck, C.H.J.
 1997
 33 S8 p. S272-
1 p.
 artikel
927 Peptide receptor therapy with 111IN-DTPA-octreotide (OC) Krenning, E.P.
 1997
 33 S8 p. S272-
1 p.
 artikel
928 Percutaneous endoscopic gastrostomy versus nasogastric tube in patients with radiation therapy for head and neck cancer: First results Anderhuber, W.
 1997
 33 S8 p. S191-
1 p.
 artikel
929 Peripheral stem cell collection (PSCC) in children. It seems to be easy: Review of the problems encountered Beaussier, P.S.
 1997
 33 S8 p. S339-
1 p.
 artikel
930 Peritoneal carcinomatosis treatmnt with curative: Institut Gustave-Roussy experience Dubé, P.
 1997
 33 S8 p. S164-
1 p.
 artikel
931 Permanent iodine-125 implants for recurrent malignant gliomas Gaspar, L.E.
 1997
 33 S8 p. S200-
1 p.
 artikel
932 Persistent lymphopenia six months after intensification with peripheral blood progenitor cells (PBPC) Dicato, M.
 1997
 33 S8 p. S95-
1 p.
 artikel
933 p53 gene mutations in primary bladder carcinoma Garcia del Muro, X.
 1997
 33 S8 p. S32-
1 p.
 artikel
934 170-P-Glycoproteins in multidrug resistance. Immunohistochemical assays with MoAb Berindan-Neagoe, loana
 1997
 33 S8 p. S183-
1 p.
 artikel
935 PGP and growth factor expression is cell cycle dependent; Expression and function is modulated by sequential TMX and IFN Seymour, L.
 1997
 33 S8 p. S177-
1 p.
 artikel
936 Pharmacokinetics and oral bioavailability of 9-amino-camptothecin PEG1000 capsules Sparreboom, A.
 1997
 33 S8 p. S246-
1 p.
 artikel
937 Pharmacokinetics of Irinotecan (CPT-11) and 5-fluorouracil (5-FU) in a dose finding study in adult patients with solid tumours Carcas, A.J.
 1997
 33 S8 p. S248-
1 p.
 artikel
938 Pharmacokinetics (PK) and pharmacodynamics (PD) of SDZ PSC 833, a novel multidrug resistance reversing agent, in phase 1 trials with chemotherapeutic agents Charnick, S.B.
 1997
 33 S8 p. S173-
1 p.
 artikel
939 Phase I and pharmacokInetic (PK) study of Irinotecan (CPT11) with a prolonged (14D) infusion schedule Herben, V.
 1997
 33 S8 p. S253-
1 p.
 artikel
940 Phase I and pharmacokinetic study of CHOP/MGBG(CM) in patients with Non-Hodgkln's-Lymphoma Thödtmann, R.
 1997
 33 S8 p. S247-
1 p.
 artikel
941 Phase I and pharmacokinetic study of ecteinascldin-743 (ET-743) given as a one hour infusion every 21 days Twelves, C.J.
 1997
 33 S8 p. S245-
1 p.
 artikel
942 Phase I and pharmacokinetic study of XelodaTM (capecitabine) in combination with docetaxel Vasey, P.A.
 1997
 33 S8 p. S246-
1 p.
 artikel
943 Phase I and pharmacoklnetic (PK) study of irinotecan (CPT-11) and cisplatin in patients with solid tumors: Preliminary results de Jonge, M.J.A.
 1997
 33 S8 p. S251-
1 p.
 artikel
944 Phase IB study of methoxymorpholinodoxorubicin (PNU 152243; FCE 23762) administered in a 3 or 4 weekly schedule de Takats, P.G
 1997
 33 S8 p. S250-S251
2 p.
 artikel
945 Phase I clinical study of ecteinascidin-743 (ET-743) as a 24 hours continuous intravenous infusion (CI) in patients (pts) with solid tumors (st): A progress report Taamma, A.
 1997
 33 S8 p. S247-S248
2 p.
 artikel
946 Phase I dose finding study of high dose vinorelbine (VNR), mitoxantrone (MTX) and cyclophosphamide (C) with bone marrow support in metastatic breast cancer (MBC) Nabholtz, J.-M.
 1997
 33 S8 p. S153-
1 p.
 artikel
947 Phase I dose finding study of irinotecan (CPT-11) over a short i.v. infusion combined with a fixed dose of 5-fluorouracil (5-FU) protracted continuous i.v. infusion in patients with advanced solid tumours Sastre, J.
 1997
 33 S8 p. S252-
1 p.
 artikel
948 Phase I dose finding study of irinotecan hydrochloride trihydrate (CPT11) with tomudex (TX.) in patients with 5-FU refractory colorectal cancer Cunningham, D.
 1997
 33 S8 p. S172-
1 p.
 artikel
949 Phase II dose-finding trial of CAELYX™ (Stealth® liposomal doxorubicin HCL) in the treatment of advanced breast cancer Ranson, M.
 1997
 33 S8 p. S148-
1 p.
 artikel
950 Phase I/II study of alternating docetaxel and mitoxantrone with G-CSF support in advanced breast cancer (ABC) Kourousis, C.
 1997
 33 S8 p. S153-S154
2 p.
 artikel
951 Phase I/II study of CPT-11 in combination with LV2FU5 (De Gramont-Regimen) every 2 weeks for the treatment of colorectal cancer (CRC) after 5FU failure Rougler, Ph.
 1997
 33 S8 p. S169-
1 p.
 artikel
952 Phase I–II study of simultaneous radiotherapy and paclitaxel (taxol) in a twice a week (TIW) schedule for recurrent squamous cell carcinomas of the head and neck (SCCHN) Becker, A.
 1997
 33 S8 p. S193-
1 p.
 artikel
953 Phase I/II study of taxol/ifosfamide/cisplatin (TIP) combination chemotherapy (CMT) in advanced solid tumors (ST) Kosmas, C.
 1997
 33 S8 p. S252-
1 p.
 artikel
954 Phase I/II study of the addition of tirapazamlne (TIRA) to cisplatine (CDDP)/navelbine (NVB) in patients with inoperable non small cell lung cancer (NSCLC) Gatineau, M.
 1997
 33 S8 p. S249-
1 p.
 artikel
955 Phase II multicentric trial of neoadjuvant bleomycin, ifosfamide and carboplatin (BIC) in locally advanced cervical cancer Murad, A.M.
 1997
 33 S8 p. S206-
1 p.
 artikel
956 Phase II multicentric trial of the use of intravenous clodronate by single fifteen day interval infusions in patients with bone osteolysis Murad, A.M.
 1997
 33 S8 p. S57-
1 p.
 artikel
957 Phase II studies of two trial regimens of topotecan as second-line single agent therapy in advanced breast cancer Spaëth, D.
 1997
 33 S8 p. S158-
1 p.
 artikel
958 Phase II studies with GI147211 (GI) in breast (B), colorectal (C) and non small cell lung cancer (N) Wanders, J.
 1997
 33 S8 p. S158-
1 p.
 artikel
959 Phase II study of a multi-targeted antifolate (LY231514) (MTA) as first line therapy in patients with locally advanced or metastatic colorectal cancer (MCC) Cripps, M.C.
 1997
 33 S8 p. S172-
1 p.
 artikel
960 Phase II study of carboplatin based chemotherapy in combination with medroxyprogesterone acetate (MPA) in advanced endometrial cancer Bafaloukos, D.
 1997
 33 S8 p. S210-S211
2 p.
 artikel
961 Phase II study of gemcltablne in patients with metastatic breast cancer Blackstein, M.
 1997
 33 S8 p. S149-
1 p.
 artikel
962 Phase II study of 24 hours-infusion of 5-fluorouracil and high dose folinic acid in patients with progressive or recurrent colorectal cancer (CRC) Hartmann, J.T.
 1997
 33 S8 p. S170-
1 p.
 artikel
963 Phase II study of interferon gamma (rIFN-G) and vinblastine(VBL) in patients with advanced renal cell carcinoma (RCC) Bacoyiannis, C.
 1997
 33 S8 p. S42-
1 p.
 artikel
964 Phase II study of intravenous RMP-7 and carboplatin for chemotherapy naïve recurrent malignant glioma Gregor, A.
 1997
 33 S8 p. S199-
1 p.
 artikel
965 Phase II study of i.v navelbine (NVB) and doxorubicln (DOX) in previously untreated advanced breast cancer (ABC) Vorobiof, D.
 1997
 33 S8 p. S155-
1 p.
 artikel
966 Phase II study of IV RMP-7 + carboplatin in recurrent malignant glioma who grade III–IV previously treated with chemotherapy Gregor, A.
 1997
 33 S8 p. S201-
1 p.
 artikel
967 Phase II study of paclitaxel as first line treatment for patients with extensive stage small cell lung cancer (SCLC) Langley, R.E.
 1997
 33 S8 p. S230-
1 p.
 artikel
968 Phase II study of taxotere/carboplatin with pharmacokinetics and -Dynamics In NSCLC for downstaging in stage III B and palliation in stage IV Griesinger, F.
 1997
 33 S8 p. S232-
1 p.
 artikel
969 Phase II study of taxotere monotherapy in previously treated patients (pts) with advanced breast cancer (ABC) Alexopoulos, C.G.
 1997
 33 S8 p. S153-
1 p.
 artikel
970 Phase II study of vinorelbine (NVB) in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck (SCCHN) Degardin, M.
 1997
 33 S8 p. S187-
1 p.
 artikel
971 Phase II study of vlnorelbine in patients with hormone refractory prostate cancer Caty, A.
 1997
 33 S8 p. S33-
1 p.
 artikel
972 Phase II study with Docetaxel (Taxotere) as second line treatment of advanced soft tissues sarcomas in adult Verusio, C.
 1997
 33 S8 p. S114-
1 p.
 artikel
973 Phase II study with 5-fluorouracil and Ginkgo Biloba extract in patients with pancreas CA Stauder, H.
 1997
 33 S8 p. S279-
1 p.
 artikel
974 Phase II trial of docetaxel and carboplatin in the treatment of advanced non-small cell lung cancer Schütte, W.
 1997
 33 S8 p. S238-
1 p.
 artikel
975 Phase II trial of i.v. navelbine (NVB) and cisplatin (CDDP) in inoperable locally advanced or disseminated NSCLC Goedhals, L.
 1997
 33 S8 p. S239-
1 p.
 artikel
976 Phase II trial of paclitaxel (P) and cisplatin (COOP) in patients with advanced breast cancer refractory to anthracycline (A) therapy Riccardi, F.
 1997
 33 S8 p. S160-
1 p.
 artikel
977 Phase II trial of the multi-targeted antifolate LY231514 (MTA) as first-line therapy for patients with advanced non-small cell lung cancer (NSCLC) Rusthoven, J.
 1997
 33 S8 p. S231-
1 p.
 artikel
978 Phase II trial of topotecan (T) as a continuous intravenous infusion in patients (PTS) with high grade gliomas Kyritsis, A.
 1997
 33 S8 p. S203-
1 p.
 artikel
979 Phase II-trial of vlnorelblne in 120-hours continuous infusion in metastatic breast cancer refractory to anthracyclines Jara, C.
 1997
 33 S8 p. S159-
1 p.
 artikel
980 Phase I study of interleukin-4 (rHuIL-4) combined with chemotherapy in gastrointestinal (GI) malignancies Bukowski, R.
 1997
 33 S8 p. S247-
1 p.
 artikel
981 Phase I study of paclitaxel (P) combined with 14-day topotecan (T) Continuous IV (CIV) infusion in previously treated and untreated patients (PTS) Hochster, H.
 1997
 33 S8 p. S250-
1 p.
 artikel
982 Phase I study of radioimmunoguided surgery (RIGS) with anti-CEA single chain Fv antibody in colorectal cancer Mayer, A.
 1997
 33 S8 p. S162-
1 p.
 artikel
983 Phase I study of the biodistribution, pharmacokinetics and immunogenicity of 111In-hCTMO1 (CDP671) ± predosing with unlabelled hCTMO1 in patients (pts) with lung cancer Verrill, M.
 1997
 33 S8 p. S246-
1 p.
 artikel
984 Phase I study of weekly clsplatln (P) and weekly or four weekly taxol (T) in patients with advanced ovarian cancer van der Burg, Mel
 1997
 33 S8 p. S245-
1 p.
 artikel
985 Phase I study of weekly docetaxel (Taxotere®) in heavily pretreated breast cancer patients Lück, H.-J.
 1997
 33 S8 p. S158-
1 p.
 artikel
986 Phase I-trial of a methotrexate — Albumin conjugate (MTX-HSA) in cancer patients Hartung, G.
 1997
 33 S8 p. S249-S250
2 p.
 artikel
987 Phase I trial of Irinotecan (CPT-11)I in childhood solid tumours Pein, F.
 1997
 33 S8 p. S249-
1 p.
 artikel
988 Phase 1 study to investigate alternate sequencing of the combination of gemcitablne and paclitaxel in ovarian carcinoma Poole, C.J.
 1997
 33 S8 p. S121-S122
2 p.
 artikel
989 Phosphotyping of c-ErbB-2 in human breast tumours Ouyang, X.
 1997
 33 S8 p. S8-
1 p.
 artikel
990 Photodynamic therapy (PDT) and fhotodynamic detection (POD) in melanoma Bloznelyté, L.
 1997
 33 S8 p. S258-
1 p.
 artikel
991 Physicians’ attitudes toward rectal cancer: Results of a French survey Arnaud, S.
 1997
 33 S8 p. S129-S130
2 p.
 artikel
992 Plasma kallikrein-kinin system in patients with tumors of reproductive system operated and submitted to radiotherapy Czokalo, M.
 1997
 33 S8 p. S212-
1 p.
 artikel
993 Platelet recovery after high-dose (HD) chemotherapy (C) is superior with peripheral blood stem cells (PBSC) mobilized by C + G-CSF compared to G-CSF alone Crump, M.
 1997
 33 S8 p. S91-
1 p.
 artikel
994 Platinum (II) complexes with phosphine-ferrocene containing ligands and their in vitro activity against leukemia AI-Allaf, Talal A.K.
 1997
 33 S8 p. S94-
1 p.
 artikel
995 p53 mutations in lung cancers of former german uranium miners Popp, W.
 1997
 33 S8 p. S236-
1 p.
 artikel
996 Pneumoperitoneum and port-site metastases in laparoscopy for cancer Reymond, M.A.
 1997
 33 S8 p. S162-
1 p.
 artikel
997 P53 nuclear reactivity and the prognosis and response to chemotherapy In patients with metastatic bladder cancer Sengeløv, L.
 1997
 33 S8 p. S31-
1 p.
 artikel
998 Polygenic inheritance of predisposition to lung cancer in experimental models Dragani, T.A.
 1997
 33 S8 p. S286-
1 p.
 artikel
999 Pooled analysis of patients (PTS) treated with topotecan (T) after progression or failure on platinum (PLAT) and paclitaxel (P) Gordon, A.
 1997
 33 S8 p. S120-
1 p.
 artikel
1000 Pooled analysis of topotecan (T) in the second-line treatment of patients (pts) with sensitive small cell lung cancer (SCLC) Eckardt, J.
 1997
 33 S8 p. S230-
1 p.
 artikel
                             1491 gevonden resultaten
 
   volgende >>
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland